Posters POSTERS

Document Sample
Posters POSTERS Powered By Docstoc
					                                                                       Posters

1482       The effect of rhinosinusitis in control of asthma in children




                                                                                                                                                                          POSTERS
           Khanbabaee, G1; Chiron, R2
           1Mofid Children Hospital, Pulmunary Ward, Tehran, Islamic Republic of Iran; 2Arnaud de vieunoud, Crcm, Montpellier, France

1483       Should chest radiography be repeated to follow up asthma in childhood?
           Özmen, S; Dibek Mýsýrlýoðlu, E; Bostancý, Ý; Giniþ, T; Doðru, M
           Ministry of Health, Ankara Dr. Sami Ulus Children’s Diseases Training and Research Hospital, Pediatric Allergy Department, Ankara, Turkey


Poster Group 2                                                                              Monday 8 June                                    12.00 – 13.30
 Diagnosis of Asthma II                                                                                                                                     Annex
Chairpersons
Ewa Jassem, Poland
Marek Sanak, Poland
767       Total nitrite levels in plasma and urine in children with acute asthma attacks
          Kucukosmanoglu, E1; Karçin, M2; Özlem, K3; Çekmen, M4; Balat, A5
          1
            Gaziantep University Medical Faculty, Pediatric Allergy, Gaziantep, Turkey; 2Gaziantep University Medical Faculty, Pediatrics, Gaziantep, Turkey; 3Ga-
          zintep Univesity Medical Faculty, Pediatric Allergy, Gaziantep, Turkey; 4Kocaaeli University Medical Faculty, Biochemistry, Kocaeli, Turkey; 5Gaziantep
          University Medical Faculty, Pediatric Nephrology, Gaziantep, Turkey
768       Abstract withdrawn
769       Fibrogenic-inflammatory markers in bronchial asthma
          Machado, D1; Pereira, C1; Robalo-Cordeiro, C2; Carvalho, L3; Loureiro, G1; Tavares, B1; Calado, G1; Ribeiro, C1; Chieira, C1
          1Coimbra University Hospitals, Immunoallergology Department, Coimbra, Portugal; 2Coimbra University Hospitals, Lung Department, Coimbra,

          Portugal; 3Coimbra University Hospitals, Anatomo-pathology Department, Coimbra, Portugal
770       Asthma control test, FeNO, functional parameters, ECP and their correlation
          Krcmova, I1; Novosad, J1; Kralickova, P1; Kleiberova, M1; Chladkova, J2; Melicharova, J1
          1School of Medicine, Charles University, Department of Clinical Immunology and Allergy, Hradec Kralove, Czech Republic; 2School of Medicine,

          Charles University, Department of Pediatrics, Hradec Kralove, Czech Republic
771       The bronchial allergen challenge (BAC) in combination with exhaled NO measurements can be used as an additional helpful tool
          for monitoring airway inflammation in patients with stable mild bronchial asthma
          Totikova, M; Nenasheva, N; Goryachkina, L; Fomina, D
          Russian Medical Academy of Post-graduate education, Clinical Allergy, Moscow, Russian Federation
772       Comparison of bronchial hyperresponsiveness from methacholine and adenosine in clinical practice
          Madero, M; Manso, L; Garcia, M; Sanchez-Garcia, S; Fernández-Nieto, M; Sastre, J
          Fundación Jiménez Diaz, Allergy Department, Madrid, Spain
773       Effect of allergen challenge on uPA and PAI-1 concentrations in induced sputum of allergic asthma patients
          Kowal, K; Moniuszko, M; Zukowski, S; Bodzenta-Lukaszyk, A
          Medical University of Bialystok, Allergology and Internal Medicine, Bialystok, Poland
774       Variability of impulse oscillometry in the assessment of respiratory function in children with asthma
          Mazon, A1; Nieto, A1; Pamies, R1; Martinez, R2; Oliver, F1; Alonso, F3; Ortuño, J1
          1
            Children’s Hospital La Fe, Pediatric Allergy Unit, Valencia, Spain; 2Hospital La Arrixaca, Service of Allergy, Murcia, Spain; 3Hospital General, Service of
          Pediatrics, Alicante, Spain
775       Relative value of FEV1 and FEV1%FVC in evaluating control of asthma in children and young adults
          Ciolkowski, J1; Henryk, M2; Stasiowska, B1
          1
            SP ZOZ, Allergy Policlinic, Lesko, Poland; 2Institute for Tuberculosis and Lung Disease, Department of Pneumonology and Cystic Fibrosis, Rabka -
          Zdroj, Poland
776       Asthma progression and airway inflammation assessed by lung function in children with asthma
          Baek, H; Oh, J; Lee, H
          Hanyang Univ. School of Medicine/Medical Center, Department of Pediatrics, Seoul, Republic of Korea
777       The link between adenosine response and allergen skin test sensitivity
          Bakirtas, A; Turktas, I
          Gazi University Faculty of Medicine, Pediatric Allergy and Asthma, Ankara, Turkey

 Treatment of Asthma II                                                                                                                                     Annex
Chairpersons
Piotr Kuna, Poland
Alberto Papi, Italy
778       Efficacy of low dose fluticasone propionate plus salmeterol compared to fluticasone propionate alone in patients with asthma
          Breskovska, G; Kaeva, B; Stevcevska, G; Stojkovic, J; Jovkovski, O
          Medical faculty, Pulmology and allergology clinic, Skopje, Macedonia, Fyrom
779       Comparison of theophylline and inhalation of fluticasone propionate as primary treatment for chronic mild to moderate asthma
          Karkinski, D
          Clinic of Pulmology, Allergy Department, Skopje, Macedonia, Fyrom
780       The efficacy of added tiotropium in the patients with controlled asthma
          Kim, W
          Hospital, Allergy and Asthma, Goyang, Republic of Korea
781       Omalizumab: pharmaco-economic evaluation in sever refractory allergic asthma
www.congrex.com/eaaci2009                                                                                               EAACI 2009 Final Programme              135
                                                                                        Posters

                    Berra, A1; Memoli, L2; Lamia, G3
POSTERS




                    1
                      Hospital, G.da Procida Hospital-Salerno-Italy, Salerno, Italy; 2Hospital, Sanitary Direction, Salerno, Italy; 3Institution, Clinic Patology, Napoli, Italy
          782       Omalizumab in severe uncontrolled asthma: a two-year clinical experience
                    Vennera, M1; Valero, A1; Bartra, J1; Muñoz, R1; Mora, R2; Picado, C1
                    1
                      Hospital Clínic, Pneumology, Barcelona, Spain; 2Novartis, Medical Department, Barcelona, Spain
          783       Omalizumab dependent asthma and sinusitis control — patient future perspectives
                    Pité, H; Chambel, M; Prates, S; Leiria Pinto, P
                    Dona Estefania Hospital, Immunoallergy Department, Lisbon, Portugal
          784       Omalizumab: effects on systemic steroid reduction and FEV1 improvement
                    Diaz, M; Calaforra, S; Ibanez, E; Lopez, R; Lis, A; Campos, A; Hernandez, D
                    Hospital La Fe, Allergy, Valencia, Spain
          785       Clinical profile and evolution of the patients treated with omalizumab in Spain
                    Chivato, T1; Prieto, L2; Ancochea, J3; Casan, P4; Picado, C5; Casafont, J6
                    1
                      Hospital Central de la Defensa, Servicio de Alergia, Madrid, Spain; 2Hospital Dr. Peset, Servicio de Alergia, Valencia, Spain; 3Hospital de la Princesa,
                    Servicio de Neumología, Madrid, Spain; 4Hospital de Sant Pau, Servicio de Neumologia, Barcelona, Spain; 5Hospital Clinic, Servicio de Neumologia,
                    Barcelona, Spain; 6Novartis Farmaceutica S.A., Departamento Medico, Barcelona, Spain
          786       Therapy with omalizumab: evaluation of effectiveness and safety in 27 patients with severe uncontrolled asthma
                    Caiaffa, M1; De Serio, A1; Bellotti, A1; Rucco, A2; Lotti, A2; Loconte, F2; Kourtis, G2; Macchia, L2
                    1
                      University of Foggia, Dept of Allergology and Clinical Immunology, Foggia, Italy; 2University of Bari, Dept of Allergology and Clinical Immunology,
                    Bari, Italy
          787       Efficacy of omalizumab in the therapy of severe persistent bronchial asthma — XCLUSIVE — compliance and utilisation investi-
                    gation under real-life conditions
                    Schumann, C1; Merk, T1; Hundack, L1; Stoiber, K1; Thielen, A2; Kroegel, C3; Hus-Marp, J1
                    1
                      Universitäsklinik Ulm, Klinik für Innere Medizin II, Pneumologie, Ulm, Germany; 2Novartis, Pharma, Nürnberg, Germany; 3Universitätsklinik Jena,
                    Pneumologie & Allergologie, Jena, Germany
          788       Omalizumab - comorbidities control in severe asthma
                    Ferreira, J1; Gomes, J2; Rosmaninho, I1; Duarte, R2; Barreira, P1; Carvalho, A2; Moreira Silva, J1
                    1
                      Centro Hospitalar Gaia/Espinho, EPE, Allergy Department, Vila Nova de Gaia, Portugal; 2Centro Hospitalar Gaia/Espinho, EPE, Pneumology Depart-
                    ment, Vila Nova de Gaia, Portugal
          789       Time course of the protective effects of omalizumab
                    Lieb, A1; Christmann, M1; Rosewich, M1; Schulze, J1; Rose, M1; Schubert, R1; Jaffe, J2; Zielen, S1
                    1
                      Johann-Wolfgang-Goethe University, Pediatric Pulmonology, Allergology and CF, Frankfurt am Main, Germany; 2Novartis Pharmaceutical Corpora-
                    tion, Translational Medicine-Respiratory, New Jersey, United States
          790       Efficacy of omalizumab in patients with concomitant allergic asthma and atopic dermatitis: a pilot study
                    Velling, P1; Skowasch, D2; Pabst, S2; Jansen, E2; Tuleta, I2; Grohé, C3
                    1
                      Evangelische Lungenklinik Berlin, Allergy Department, Berlin, Germany; 2Department of Internal Medicine II, University of Bonn, Pneumology,
                    Bonn, Germany; 3Evangelische Lungenklinik Berlin, Pneumology, Berlin, Germany

           Experimental Models of Asthma                                                                                                                             Annex
          Chairpersons
          Martien Kapsenberg, The Netherlands
          Marco Idzko, Germany
          791       Characterisation of a short-term adjuvant-free asthma model in BALB/c mice
                    Litvin, L1; Babakhin, A1; Barsegjan, G2; Ivanova, A3; Khaitov, M1
                    1
                      NRC Institute of Immunology, Nano and Biomedical Technologies, Moscow, Russian Federation; 2All-Russia Research Center of Molecular Diagnos-
                    tics and Treatment, Toxicology, Moscow, Russian Federation; 3NRC Institute of Immunology, Immunepharmacology and Drug Toxicology, Moscow,
                    Russian Federation
          792       The novel acute adjuvant-free murine model of bronchial asthma induced by timothy pollen allergen
                    Nickolay, K; Babakhin, A; Bashkatova, Y; Martynov, A; Khaitov, M
                    NRC Institute of Immunology FMBA Russia, Nano and Biomedical Technologies Lab, Moscow, Russian Federation
          793       Histopathologic changes in two different mouse models of asthma
                    Olmez, D1; Babayigit, A1; Erbil, G2; Karaman, O1; Bagriyanik, A2; Yilmaz, O3; Uzuner, N1
                    1
                      Dokuz Eylul University Hospital, Department of Pediatric Allergy, Izmir, Turkey; 2Dokuz Eylul University Hospital, Department of Histology and
                    Embriology, Izmir, Turkey; 3Dokuz Eylul University Hospital, Department of Experimental Animal Laboratory, Izmir, Turkey
          794       Aged garlic extract modulates allergic airway inflammation in Balb/c mice
                    Zare, A1; Farzaneh, P2; Pourpak, Z2; Hassan, Z3; Moin, M2
                    1
                      Tehran University of Medical Sciences, Immunology, Asthma and Allergy Research Institute, Tehran, Islamic Republic of Iran; 2Tehran University of
                    Medical Sciences I.R. Iran, Immunology, Asthma and Allergy Research Institute, Tehran, Islamic Republic of Iran; 3Tarbiat Modarres University,
                    Tehran, Iran., Department of Immunology, School of Medical Scien, Tehran, Islamic Republic of Iran
          795       A novel murine model of hexamethylene diisocyanate-induced asthma
                    Sun, L1; Florvaag, E1; Aasen, T2; Do, T3; Aardal, N4; Vaali, K1
                    1University of Bergen, Institute of Medicine, Bergen, Norway; 2Haukeland University Hospital, Department of Occupational Medicine, Bergen, Nor-

                    way; 3Haukeland University Hospital, Laboratory of Clinical Biochemistry, Bergen, Norway; 4Haukeland University Hospital, Department of Patho-
                    logy, Bergen, Norway
          796       Factors which influence the phenotype in mouse models of chronic asthma
                    Kim, T1; Jang, M1; Moon, K1; Bae, Y1; Park, C1; Lee, J2; Cho, Y1; Moon, H1
                    1Asan Medical Center, University of Ulsan College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea; 2School of Medicine,

                    Cheju National University, Department of Medicine, Jeju, Republic of Korea

           136      EAACI 2009 Final Programme                                                                                             www.congrex.com/eaaci2009
                                                                     Posters

797       Characterisation of the delayed humoral responses to self heat shock protein 70 following the sensitisation phase in an mouse




                                                                                                                                                                      POSTERS
          model of asthma
          Shekhovtsova, E; Sapozhnikov, A; Shevchenko, M
          Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Immunology, Moscow, Russian Federation
798       Modulation of dendritic cells by calcitonin-gene related peptide
          Rochlitzer, S1; Krug, N2; Braun, A1
          1
           Fraunhofer Institute for Toxicology and Experimental Medicine, Immunology, Allergology and Immunotoxicology, Hannover, Germany; 2Fraunho-
          fer Institute for Toxicology and Experimental Medicine, Clinical Airway Research, Hannover, Germany
799       5-Hydroxytryptamine modulates migration, cytokine and chemokine release and T cell priming capacity of human dendritic
          cells
          Mueller, T; Duerk, T; Idzko, M
          University Hospital Freiburg, Pneumology, Freiburg, Germany
800       Therapeutic effect of ectoine in an experimental model of allergic asthma
          Bilstein, A1; Hoymann, H2; Bernal, F1; Stoehr, T1; Lentzen, G1
          1Bitop AG, MP, Witten, Germany; 2Fraunhofer Institute of Toxicology and Experimental Medicine (ITEM), Pre-clinical Airway Research, Hannover,

          Germany
801       Effects of BCG vaccination time on allergic response in animal model of asthma
          Karakoc, G1; Tepe, T1; Yilmaz, M1; Gumurdulu, D2; Daglioglu, K3; Altintas, D1; Inal, A1; Kendirli, S1
          1Cukurova University, Pediatric Allergy-Immunology, Adana, Turkey; 2Cukurova University, Pathology, Adana, Turkey; 3Cukurova University, Animal

          Research Laboratory, Adana, Turkey
802       Resistance to MHC I- and MHC II -induced apoptosis is dependent upon serum factors and Bcl-2 expression in peripheral blood
          mononuclear cells from patients with atopic bronchial asthma
          Mamontova, T
          Ukrainian Medical Stomatological Academy, Central Reserch Laboratory, Poltava, Ukraine
803       Abstract withdrawn

 Pediatric Asthma I                                                                                                                                     Annex
Chairpersons
Fotini Saxoni-Papergiou, Greece
Lis Grzegorz, Poland
804        Comparison of different tools in predicting childhood asthma exacerbations and altered clinical status
           Leung, T1; Ko, F2; Wong, G1; Hui, D2; Lai, C2
           1The Chinese University of Hong Kong, Department of Paediatrics, Hong Kong, Hong Kong; 2The Chinese University of Hong Kong, Department of

           Medicine and Therapeutics, Hong Kong, Hong Kong
805        Skin test reactivity to fungal aeroallergens in asthmatic children in southern Iran
           Moghtaderi, M1; Amin, R2; Kashef, S1
           1Nemazee Hospital, Pediatric Immunology and Allergy Ward, Shiraz, Islamic Republic of Iran; 2Nemazz Hospital, Pediatric Immunology and Allergy,

           Shiraz, Islamic Republic of Iran
806        Is regular exercise protective against asthma?
           Vlaski, E1; Stavric, K2; Kimovska, M1; Seckova, L1; Iseni, A3; Collaborative Team of, t4
           1University Children’s Hospital, Department of Pulmonology and Allergology, 1000 Skopje, Macedonia, Fyrom; 2University Children’s Hospital, De-

           partment of Immunology, 1000 Skopje, Macedonia, Fyrom; 3Private Health Organization, Department of Paediatrics, Kumanovo, Macedonia,
           Fyrom; 4Public Health Organization, Department of Paediatrics, Tetovo, Ohrid, Veles, Berovo, Pehcevo, Delcevo, Macedonia, Fyrom
807        Depressive symptoms amongst asthmatic children’s caregivers in Hungary
           Szabó, A; Mezei, G; Kõvári, É; Cserháti, E
           Semmelweis University, First Department of Pediatrics, Budapest, Hungary
808        Assesment of exercise induced asthma in asthmatic children
           Amin, R1; Faeezi, A2; Kashef, S2; Alyasins, S2
           1Shiraz University of Medical Science, Allergy research lab - Pediatric Department, Shiraz, Islamic Republic of Iran; 2Shiraz University of Medical Sci-

           ence, Pediatric Department, Shiraz, Islamic Republic of Iran
809        Prevalence of obesity and overweight in an Austrian pediatric allergy and asthma clinic
           Grafenauer, P; Zach, M; Varga, E
           Medical University Graz, Dep.of Paediatrics,Respiratory and Allergic Diseas, Graz, Austria
810        Characterisation of the asthmatic population referred for the first time to a pediatric/allergy out-patient clinic during adole-
           scence
           Martins, S; Fraga, J; Pereira, A; Ferreira, N; Quaresma, M
           Centro Hospitalar de Trás-os-Montes e Alto Douro, Serviço de Pediatria, Vila Real, Portugal
811        The pattern of the flow volume curve in non-asthmatic children aged 12-15 years
           Iwata, T1; Kodachi, Y2; Kano, H2; Hara, H3; Takeuchi, H4
           1Tokyo Kasei University, Child Health and Development, Tokyo, Japan; 2Tokyo University, Medicine, Tokyo, Japan; 3Kokugakuin University, Sports and

           Physical Culture, Tokyo, Japan; 4Tokyo University, Health Science, Tokyo, Japan
812        Changes in lung function in childhood asthma
           Macheska - Badzakova, G
           PHO “Pulmo - Allergology”, Pediatric pulmo - allergology, Skopje, Macedonia, Fyrom




www.congrex.com/eaaci2009                                                                                            EAACI 2009 Final Programme             137
                                                                                      Posters

          813       Recurrent bronchoobstructive syndrome in early age with respiratory disorders during the neonatal period: optimisation of a
POSTERS




                    preventive programme
                    Matsyura, O1; Besh, L2
                    1Lviv City Children’s Clinical Hospital, Allergy Department, Lviv, Ukraine; 2Danylo Halytsky Lviv National Medical University, Allergy Department, Lviv,

                    Ukraine
          814       Prednisone versus prednisolone in the treatment of acute attack of asthma in hospitalised children
                    Bizhga, M; Vevecka, E
                    Mother Teresa UHC, Dept of Pediatrics, Tirane, Albania
          815       Association of anti-allergic prophylaxis and asthma: result from the ECAP study (Epidemiology of allergic disorders in Poland)
                    Lusawa, A; Raciborski, F; Tomaszewska, A; Walkiewicz, A; Samel-Kowalik, P; Borowicz, J; Samolinski, B
                    Medical University of Warsaw, Prevention of Environmental Hazards & Allergology, Warsaw, Poland
          816       Association of the RANTES gene promoter polymorphisms with atopic asthma in Greek children
                    Tsakiridis, P1; Pappa, S1; Sakelaropoulou, A1; Emboriadou, M1; Haidopoulou, K2; Hatzistilianou, M1
                    1Aristotle University, 2nd Department of Paediatrics, Thessaloniky, Greece; 2Aristotle University, 4th Department of Paediatrics, Thessaloniki, Greece

          817       Abstract withdrawn
          817b      Urban/rural differences in diet and atopic diseases
                    Vlaski, E1; Seckova, L1; Stavric, K2; Kimovska, M1; Nikolovski, L1; Kirovski, I1
                    1University Children’s Hospital, Department of Pulmonology and Allergology, Skopje, Macedonia, Fyrom; 2University Children’s Hospital, Depart-

                    ment of Immunology, Skopje, Macedonia, Fyrom

           Pediatric Allergy - Risk Factors                                                                                                                      Annex
          Chairpersons
          Magnus Wickman, Sweden
          Derya Altintas, Turkey
          818       Delivery by cesarian is not related to cord blood IgE or skin prick test results at age 2 years
                    Havstad, S1; Zoratti, E2; Ownby, D3; Johnson, C1; Wegienka, G1
                    1Henry Ford Hospital, Department of Biostatistics and Research Epidemiol, Detroit, United States; 2Henry Ford Hospital, Department of Allergy and

                    Clinical Immunology, Detroit, United States; 3Medical College of Georgia, Department of Pediatrics, Augusta, United States
          819       Different sensitisation profile for asthma and rhinitis among Korean adolescents
                    Song, Y; Kim, B; Jin, H; Kim, B; Yu, J; Hong, S
                    Asan Medical Center, Allergy/Immunology, Seoul, Republic of Korea
          820       LAPIZ: an epidemiological study of allergy diseases
                    Segura, N1; Sobrevia, M1; Lezaun, A1; Rojas, B2; Sierra, J1; Cubero, J1; Colas, C1
                    1HCU, Allergy, Zaragoza, Spain; 2HRV, Allergy, Zaragoza, Spain

          821       Life style during pregnancy and immunoglobulins in cord blood. Baseline data from ALADDIN — a birth cohort study
                    Stenius, F1; Lilja, G1; Swartz, J2; Dahlström, J3; Borres, M3; Pershagen, G4; Scheynius, A5; Alm, J1
                    1
                     Karolinska Institutet, Sachs´Childrens Hospital, Stockholm, Sweden; 2Vidar Clinic, Out Patient Clinic, Järna, Sweden; 3Phadia, Medical Department,
                    Uppsala, Sweden; 4Karolinska Institutet, Institute of Environmental Medicine, Solna, Sweden; 5Karolinska Institutet, Department of Medicine Solna,
                    Solna, Sweden
          822       Rinsing skin surface sweat with shower at school could yield a countermeasure to atopic dermatitis in elementary school stu-
                    dents
                    Matsui, S; Aya, T; Shun, K; Hiroyuki, M; Katayama, I
                    Osaka University, Dermatology, Suita, Japan
          823       Parental risk factors are associated with symptoms of food hypersensitivity in school-children
                    Majkowska-Wojciechowska, B; Wardzynska, A; Luczynska, M; Kowalski, M; Kowalski, M
                    Medical University of Lodz, Dpt of Immunology, Rheumatology and Allergy, Lodz, Poland
          824       Out-door environmental factors and allergic diseases
                    Piekarska, B; Furmañczyk, K; Lipiec, A; Walkiewicz, A; Raciborski, F; Samolinski, B
                    Medical University of Warsaw, Dep. of Prevention of Environmental Hazards, Warsaw, Poland
          825       Paracetamol use and asthma symptoms and allergic rhinitis — data analysis of ECAP study
                    Lipiec, A; Wawrzyniak, Z; Piekarska, B; Samolinska-Zawisza, U; Samolinski, B
                    Medical University of Warsaw, 1. Department of the Prevention of Environmental H, Warszawa, Poland
          826       Information and communication technology for the risk assessment and diagnostic patterns of allergy
                    Quaglini, S1; De Amici, M2; Cerra, C3; Ciprandi, G4; Marseglia, G2; Concaro, S1; Carugno, B5
                    1University of Study of Pavia, Computer Engineering and Systems Science, Pavia, Italy; 2Foundation IRCCS Policlinic S Matteo, Department of Pedi-

                    atrics, Pavia, Italy; 3ASL of Pavia, Sistema Informativo Aziendale, Pavia, Italy; 4Azienda Ospedaliera Universitaria San Martino, University of Genoa,
                    Department of Internal Medicine, Pavia, Italy; 5ASL of Pavia, Department of PAC, Pavia, Italy
          827       Correlation between pet ownership and sensitisation to animal allergens in patients with allergic diseases
                    Jeong-Hee, C; Ji-Yeon, H; Yong-Bum, P; Eun-Kyung, M
                    Hallym University Kangdong Sacred Heart Hospital, Pulmonology and Allergy, Seoul, Republic of Korea
          828       Allergen-specific IgE in sera of infants in the Saratov region
                    Astafyeva, N1; Udovichenko, E2; Perfilova, I2
                    1State Educational Institution of Higher Professional Education Saratov State Medical University of Roszdrav, Department of Clinical Immunology,

                    Allergology, Saratov, Russian Federation; 2State Educational Institution of Higher Professional Education Saratov State Medical University of
                    Roszdrav”, Department of Clinical Immunology, Allergology, Saratov, Russian Federation




           138       EAACI 2009 Final Programme                                                                                         www.congrex.com/eaaci2009
                                                                     Posters

830       Air pollution as a risk factor related to the prevalence of allergic diseases in the children of Moldova




                                                                                                                                                                     POSTERS
          Cirstea, O; Vasilos, L; Cojocaru, A; Horodisteanu-Banuh, A; Arama, M; Savoschin, D
          Research Institute for Mother and Child Health Care, Department of Pediatrics, Chisinau, Moldova, Republic of
831       Pulmonary function test in transfusion-dependent beta-thalassemia children
          Alyasins, S1; Moghtaderi, M2; Kashef, S2; Amin, R2
          1Shiraz University of Medical Science, Allergy Research lab - Pediatric Department, Shiraz, Islamic Republic of Iran; 2Shiraz University of Medical Sci-

          ence, Pediatric Department, Shiraz, Islamic Republic of Iran
832       Asthma as a complication of bronchiectasis (or conversely) in children
          Maneva, M; Stojanovska, L; Petrusevska, L; Boskovska, K
          Institute for respiratory diseases in children-Kozle, Chronic lung diseases in children, Skopje, Macedonia, Fyrom
833       Bronchial asthma of children at the modern stage
          Panahova, T; Sultanova, N
          Azerbaijan Medical University, Chair of Pedriatics, Baku, Azerbaijan
833b      The effect of moisturiser intervention for newborns with atopic disposition
          Takahashi, A; Matsui, S; Kitaba, S; Murota, H; Katayama, I
          Osaka University, Dermatology, Suita, Japan

 Pediatric Epidemiology II                                                                                                                              Annex
Chairpersons
José Manuel Lopes dos Santos, Portugal
Ana Maria Plaza, Spain
834       Grass pollen allergy: factors associated with an asthma phenotype in patients from Spain
          Fernández-Rivas, M1; Barreales Tolosa, L2; Vázquez-Cortés, S1; Zayas, L1; Rodríguez-Jiménez, B3; Fernández, C2; Martínez Cócera, C1
          1
            Hospital Clínico San Carlos, Allergy Department, Madrid, Spain; 2Hospital Clínico San Carlos, Epidemiology Department, Madrid, Spain; 3Hospital
          Getafe, Allergy Department, Madrid, Spain
835       An epidemiological study in children (LAPIZ)
          Segura, N; Sobrevia, M; Lezaun, A; Goienetxe, E; Garces, M; Ferrer, L; Colas, C
          HCU, Allergy, Zaragoza, Spain
836       Prevalence of allergic diseases in Poland — ECAP study
          Samolinski, B1; Tomaszewska, A1; Raciborski, F1; Samel-Kowalik, P1; Walkiewicz, A1; Lusawa, A1; Gutowska, J1; Trzpil, L1; Samolinska-Zawisza, U1; Halat,
          Z1; Jakubik, N1; Marszalkowska, J1; Paczesny, D2; Samoliñski, L1
          1
            Medical University of Warsaw, Dep. of Prevention of Environmental Hazards, Warsaw, Poland; 2Warsaw University of Technology, Institute of
          Electronic System, Warsaw, Poland
837       Age stratification of allergic diseases by gender in children and adolescents from Western Hungary assessed from 2006 to 2008
          Soti, L1; Petz, Z1; Bodecs, T2; Endre, L3; DuBuske, L4
          1
            Allergy-Asthma Outpatient Clinic, Allergy, Szombathely, Hungary; 2University of Pecs, Faculty of Health Sciences, Pecs, Hungary; 3National Health
          Institute, Department of Allergy and Immunology, Budapest, Hungary; 4Immunology Research Institute of New England, Department of Allergy
          and Immunology, Gardner, MA, United States
838       Relationship between asthma and allergic rhinitis in the urban and rural area — ECAP study
          Tomaszewska, A; Samel-Kowalik, P; Lusawa, A; Walkiewicz, A; Raciborski, F; Borowicz, J; Gutowska, J; Samolinski, B
          Medical University of Warsaw, Prevention of Environmental Hazards and Allergolgy, Warsaw, Poland
839       Is there an increased risk for atherosclerosis in children with asthma?
          Olmez, D1; Babayigit, A1; Demircioglu, F2; Kocyigit, A3; Uysal, F3; Karaman, O1; Cakmakci, H3; Uzuner, N1
          1Dokuz Eylul University Hospital, Department of Pediatric Allergy, Izmir, Turkey; 2Dokuz Eylul University Hospital, Department of Pediatric Hemato-

          logy, Izmir, Turkey; 3Dokuz Eylul University Hospital, Department of Radiology, Izmir, Turkey
840       Seasonal (monthly) variation in asthma exacerbations, in patients with asthma, in Greece
          Vourdas, D; Petalas, K; Grigoreas, C
          251 General Air Force Hospital, Allergology, Athens, Greece
841       Confirmed association between neonatal phototherapy and the risk of childhood asthma
          Aspberg, S1; Dahlquist, G2; Kahan, T1; Källén, B3
          1
            Karolinska Institutet, Danderyd Hospital, Department of Clinical Sciences, Stockholm, Sweden; 2Umeå Universitet, Department of Clinical Scien-
          ces, Paediatrics, Umeå, Sweden; 3Lunds Universitet, Tornblad Institutet, Lund, Sweden
842       Pulmonary obstruction changes in childhood cancer survivors - treatment complications or asthma?
          Wasilewska, E1; Jassem, E1; Kuziemski, K1; Kaczorowska-Hac, B2; Niedzwiecki, M2; Niedoszytko, M1; Balcerska, A2
          1
            Medical University Gdansk, Allergology Department, Gdansk, Poland; 2Medical University Gdansk, Pediatric, Haematology, Oncology Department,
          Gdansk, Poland
843       Exhaled nitric oxide levels in children from Zaragoza (Spain)
          Sobrevia, M; Segura, N; Lezaun, A; Ferrer, L; Sierra, J; Cubero, J; Colas, C
          Hospital Clinico, Allergy Department, Zaragoza, Spain
844       Significant increase of polysensitisation in allergic rhinoconjunctivitis among adolescent and adult patients living in urban
          areas since 1980
          Lang-Loidolt, D1; Tomazic, P1; Köle, W1; Narkus, A2
          1Medical University of Graz, ENT, Graz, Austria; 2Allergopharma, J. Ganzer KG, Reinbek, Germany

845       Establishing the sequential progression of multiple allergic diagnoses in a retrospective birth cohort
          Punekar, Y1; Sheikh, A2
          1
            Schering-Plough Ltd, Market Access & Communications, London, United Kingdom; 2GP Section University of Edinburgh, Division of Community
          Health Sciences, Edinburgh, United Kingdom

www.congrex.com/eaaci2009                                                                                           EAACI 2009 Final Programme              139
                                                                                         Posters

          846        Sensitisation to food and aeroallergens in patients of developmental age
POSTERS




                     Kaczmarski, M1; Wasilewska, J1; Citko, D2
                     1Medical University, Department of Pediatrics and Allergology, Bialystok, Poland; 2Medical University, Department of Statistics and Medical Infor-

                     matics, Bialystok, Poland
          847        Alternaria sensitisation and allergic rhinitis, with or without asthma, in the French six cities study
                     Randriamanantany, Z1; Annesi-Maesano, I2; Moreau, D3; Raherison, C4; Charpin, D5; Kopferschmitt, M6; Lavaud, F7; Taytard, A8; Caillaud, D1
                     1
                       CHU Gabriel Montpied, Service de Pneumologie, Clermont Ferrand, France; 2INSERM U707 , Faculté Médecine Saint-Antoine, EPAR, Paris, France;
                     3INSERM U707, Faculté Médecine Saint-Antoine, EPAR, Paris, France; 4Hôpital du Haut Leveque, Service des Maladies Respiratoirs, Pessac, France;
                     5Hôpital Nord, Pneumologie, Marseille, France; 6Hôpitaux Civils, Pneumologie, Strasbourg, France; 7Hôpital Maison Blanche, Pneumologie, Reims,

                     France; 8Hôpital du Haut Leveque, Service des Maladies Respiratoires, Pessac, France
          848        The estimation of conformability between the questionnaire diagnosis of asthma and the diagnosis based on clinical examina-
                     tion. ECAP study = Epidemiology of allergic diseases in Poland
                     Komorowski, J; Samolinski, B; Rabczenko, D; Sybilski, A
                     Medical University of Warsaw, Prevention of Environmental Hazards and Allergolog, Warsaw, Poland
          849        Prevalence of elevated exhaled nitric oxide and atopy in school-children from Porto, Portugal
                     Silva, R; Cruz, L; Vieira, T; Leblanc, A; Reis Ferreira, A; Fonseca, J; Moreira, A; Castel-Branco, M
                     Hospital S. João, EPE, Allergy Division, Porto, Portugal
          850        Characteristics and prognosis of childhood atopic dermatitis: a multi-center study in Turkey
                     Yuksel, H1; Can, D2; Reisli, I3; Uzuner, N4; Orhan, F5; Cevit, O6; Tahan, F7; Canitez, Y8; Kuyucu, S9; Bingol Boz, A10; Akcay, A11; Yilmaz, O1
                     1Celal Bayar University Medical Faculty, Pediatric Allergy and Pulmonology, Manisa, Turkey; 2Behcet Uz Children’s Hospital, Pediatric Allergy, Izmir,

                     Turkey; 3Selcuk University Meram Medical Faculty, Pediatric Immunology and Allergy, Konya, Turkey; 4Dokuz Eylül University Medical Faculty, Pedi-
                     atric Allergy, Izmir, Turkey; 5Karadeniz Technical University Medical Faculty, Pediatric Allergy, Trabzon, Turkey; 6Cumhuriyet University Medical Fac-
                     ulty, Pediatric Allergy, Sivas, Turkey; 7Erciyes University Medical Faculty, Pediatric Allergy, Kayseri, Turkey; 8Uludag University Medical Faculty,
                     Pediatric Allergy, Bursa, Turkey; 9Mersin University Medical Faculty, Pediatric Allergy, Mersin, Turkey; 10Akdeniz University Medical Faculty, Pediatric
                     Allery, Antalya, Turkey; 11Pamukkale University Medical Faculty, Pediatric Allergy, Denizli, Turkey

           Rhinitis and Comorbidities                                                                                                                                 Annex
          Chairpersons
          Claus Bachert, Belgium
          Mario Zernotti, Argentina
          851       Allergic rhinitis is prevalent in infants with asthma
                    Chong Neto, H; Westphal, G; Rosario, N; Riedi, C; Santos, H; Takizawa, K; Souza, R; Aguilera, C
                    University of Parana, Department of Pediatrics, Curitiba, Brazil
          852       Abnormal pulmonary function test in children with allergic rhinitis due to house dust mites without asthma
                    Rha, Y1; Kim, M2
                    1Kyunghee University Hospital, Departement of Pediatrics, Seoul, Republic of Korea; 2Hyosung Children’s Hospital, Department of Pediatrics,

                    Daegu, Republic of Korea
          853       Rhinosinusitis with nasal polyposis in patients with and without bronchial asthma
                    Olszewska-Ziaber, A; Kowalski, M
                    Medical University of Lodz, Department of Immunology, Rheumatology and Allergy, Lódz, Poland
          854       Two disease, allergic rhinitis and bronchiala asthma?
                    Cioaca, G; Paunescu, V; Staicus, M
                    University of Medicine and Pharmacy Victor Babes Timisoara, Department of Immunology, Timisoara, Romania
          855       Clinical patterns and co morbidities of allergic rhinitis: a retrospective study in a tertiary reference hospital
                    Koulouris, S; Makris, M; Sideri, K; Spanoudaki, N; Koti, I; Chliva, C; Kalogeromitros, D
                    Allergy Unit, ¨Attikon¨ University Hospital, Medical School, Athens University, Allergy Unit, Athens, Greece
          856       Clinical profile of patients with allergic rhinitis induced by grass pollen: the findings of the Spanish PETRA study
                    Valero, A1; Justicia, J2; Alvà, V2; García, M3
                    1
                      Clinic Hospital, Allergy Unit, Barcelona, Spain; 2Stallergenes Ibérica, Medical Department, Barcelona, Spain; 3Biometrica Group, Biometría Clínica,
                    Barcelona, Spain
          857       The clinical profile of patients with allergic rhinitis induced by house dust mites: the findings of the Spanish PETRA study
                    Alvà, V1; Valero, A2; Justicia, J1; García, M3
                    1
                      Stallergenes Ibérica, Medical Department, Barcelona, Spain; 2Clinic Hospital, Allergy Unit, Barcelona, Spain; 3Biometrica Group, Biometría Clínica,
                    Barcelona, Spain
          858       Prevalence of allergic rhinitis in patients with asthma in Algiers
                    Gharnaout, M; Douagui, H
                    Hospital, Pneumology-Allergology and Thoracic Oncology, Algiers, Algeria
          859       Influence of daytime sleepiness on pollinosis symptom and QOL in patients with Japanese cedar pollinosis
                    Kato, C1; Takeuchi, N1; Ito, M1; Minami, Y1; Ogino, S1; Arimoto, H2; Irifune, M2; Iwata, N2; Ookawauchi, I2; Kikumori, H2; Seo, R2; Takeda, M2; Tamaki, A2;
                    Baba, K2; Nose, M2
                    1
                      Graduate School of Allied Health Sciences, Faculty of Medicine, Osaka, Japan; 2Osaka Health Care and Allergy Supporting Systems, Osaka Health
                    Care and Allergy Supporting Systems, Osaka, Japan
          860       Storage mites sensitivity in patients suffering from perennial rhinitis – preliminary results
                    Tworek, D1; Kuprys-Lipinska, I1; Zielinska-Wyderkiewicz, E2; Bochenska-Marciniak, M2; Kuna, P1
                    1
                      Barlicki University Hospital, Division of Internal Medicine, Asthma and Allergy, Lodz, Poland; 2Barlicki University Hospital, Division of Pulmonology
                    and Allergy, Lodz, Poland



           140       EAACI 2009 Final Programme                                                                                             www.congrex.com/eaaci2009
                                                                    Posters

861       When allergic rhinitis is not only allergic




                                                                                                                                                                    POSTERS
          Gelardi, M1; Russo, C1; Fiorella, M1; Fiorella, R1; Canonica, G2; Passalacqua, G2
          1Department of Otolaryngology II, University of Bari, Bari, Italy; 2Genoa University, Allergy & Respiratory Diseases, Dept of Internal Medicine, Genoa,

          Italy
862       Anterior and posterior nasal symptom scores in allergic and nonallergic rhinitis
          Merck, S; Ravindran, M; Baraniuk, J
          Georgetown University, Division of Rheumatology, Immunology & Allergy, Washington, DC, United States
863       Clinical evaluation of non-allergic rhinitis and its impact on health-related quality of life
          Doña, I; Rondon, C; Torres, M; Campo, P; Romero, J; Chaves, P; Cornejo, J; Blanca, M
          Carlos Haya Hospital, Allergy Service, Malaga, Spain
864       Evaluation of severity, pharmacotherapy and impact on work productivity in allergic and non-allergic rhinitis
          Rondon, C1; Doña, I1; Campo, P1; Torres, M1; Romero, J1; Lopez, S2; Blanca, M1
          1Carlos Haya Hospital, Allergy Service, Malaga, Spain; 2Carlos Haya Hospital-Fundación IMABIS, Research Laboratory, Malaga, Spain

865       The incidence, severity and duration of otitis media reduced with fluticasone furoate nasal spray compared to placebo in two
          pediatric studies
          Maspero, J1; Clements, D2; Philpot, E2
          1Fundacion CIDEA, Clinical Research, Buenos Aires, Argentina; 2GlaxoSmithKline, Respiratory Medicine Development Centre, Research Triangle Park,

          United States
866       Quality of life and work productivity in allergic rhinitis patients suffering from both nasal and ocular symptoms - an observatio-
          nal, cross sectional study in 4 countries in Europe
          Gueron, B1; Demoly, P2; Mullol, J3; Virchow, J4; Kay, S5; Cristino, J6; Canonica, G7
          1
            GSK, European Respiratory Centre of Excellence, Marly le Roi, France; 2CHU Montpellier, INSERM U657, Montpellier, France; 3Hopsital Clinic i Uni-
          versitary, Rinology Unit, Barcelona, Spain; 4Universitatsklinic Rostock, Pneumology, Rostock, Germany; 5Adelphi Group Product, Adelphi, London,
          United Kingdom; 6Adelphi Group, Adelphi, London, United Kingdom; 7Clinica Delle Malattie del Apparato Respiratorio, Allergologia, Genova, Italy
867       Impact of ocular symptoms on resource utilisation and work productivity in management of AR- an observational, cross sectio-
          nal study in 4 countries in Europe
          Gueron, B1; Demoly, P2; Mullol, J3; Virchow, J4; Stephen, K5; Cristino, J6; Canonica, G7
          1GSK, European Respiratory Centre of Excellence, Marly le Roi, France; 2CHU Montpellier., INSERM U657, Montpellier, France; 3Hospital Clinic i Uni-

          versitary, Rinology unit, Barcelona, Spain; 4Universitatsklinic Rostock, Pneumology, Rostock, Germany; 5Adelphi Group Product, Adelphi, London,
          United Kingdom; 6Adelphi Group, Adelphi, London, United Kingdom; 7Clinica del Apparato Respiratory, Allergy, Genova, Italy

 Insect Venom Hypersensitivity                                                                                                                        Annex
Chairpersons
Franziska Ruëff, Germany
Gunter Sturm, Austria
868        Allergy to bee and wasp venom and associations with HLA Class II
           Kucera, P1; Cerna, M2; Hulikova, K3
           1
             3rd Medical Faculty, Charles University, Dept Immunology, Prague, Czech Republic; 23rd Medical Faculty, Charles University, Dept Generaliology
           Genetics, Prague 10, Czech Republic; 33rd Medical Faculty, Charles University, Dept Immunology, Prague 10, Czech Republic
869        Atopic status in double positive patients with stinging insect allergy and specific IgE to carbohydrates epitopes
           Erzen, R; Music, E; Korosec, P; Silar, M; Kosnik, M
           Hospital Golnik, Allergy department, Golnik, Slovenia
870        Interleukine 2 -330 G/T promoter gene polymorphism in patients with insect venom allergy
           Niedoszytko, M1; Ratajska, M2; Chelmiñska, M1; Galewska, K2; Gorska, L1; Limon, J2; Jassem, E1
           1
             Medical University of Gdañsk, Allergology, Gdañsk, Poland; 2Medical University of Gdansk, Biology and Genetics, Gdañsk, Poland
871        Self-reported insect sting allergy among adults in the R. Macedonia
           Stoleski, S1; Karadzinska-Bislimovska, J1; Minov, J1; Mijakoski, D2; Risteska-Kuc, S3; Ezova, N2; Marsenic, M2; Milkovska, S2
           1
             Institute of Occupational Health-WHO Collaborating Center, Ga2len Collaborating Center, Skopje, R. Macedonia, Dpt for Cardiorespiratory Functio-
           nal Diagnostics, Skopje, Macedonia, Fyrom; 2Institute of Occupational Health-WHO Collaborating Center, Ga2len Collaborating Center, Skopje, R.
           Macedonia, Allergy Center, Skopje, Macedonia, Fyrom; 3Institute of Occupational Health-WHO Collaborating Center, Ga2len Collaborating Center,
           Skopje, R. Macedonia, Dpt for Occupational diseases, Skopje, Macedonia, Fyrom
872        Hymenoptera venom allergy: prevalence in a rural population of Southern of Italy. Pilot study
           Patella, V; Florio, G
           Allergy and Clinical Immunology Unit, Department of Medicine of ASL SA/3, Salerno, Italy
873        Hymenoptera venom allergy in the fire brigade of Valencia, Spain
           Cabrera, R; Fernandez, J; Rubio, G
           Miguel Hernández University, Medicine Department, San Juan de Alicante, Spain
874        The doubtful existence of IgE-negative anaphylaxis after hymenoptera sting
           Bilò, B; Brianzoni, M; Frontini, F; Cinti, B; Bonifazi, F
           Ospedali Riuniti, Department of Internal Medicine - Allergy Unit, Ancona, Italy
875        Anaphylaxis after Siberian dwarf hamster bite
           Kjaer, S1; Skov, P2; Öman, H3; Lundberg, M3; Johnsen, C1
           1
             Region Sealand, Roskilde Hospital, Medical Department, Roskilde, Denmark; 2RefLab, Laboratory Department, Copenhagen, Denmark; 3Phadia AB,
           Diagnostic Department, Uppsala, Sweden




www.congrex.com/eaaci2009                                                                                          EAACI 2009 Final Programme             141
                                                                                       Posters

          876       Insect stings can cause aphasia: a case report
POSTERS




                    Mansouri, M1; Mahvelati, F2; Karimzade, P2; Tonekaboni, H2
                    1Shaheed Beheshti Medical University, Allergy & Immunology, Tehran, Islamic Republic of Iran; 2Shaheed Beheshti Medical University, Mofid Child-

                    ren Hospital, Neurology, Tehran, Islamic Republic of Iran
          877       Low sensitivity of venom skin prick tests in patients with severe anaphylactic reactions to hymenoptera stings
                    Korosec, P; Silar, M; Kopac, P; Erzen, R; Bajrovic, N; Kosnik, M
                    University Clinic of Respiratory and Allergic Diseases, Lab. for Clinical Immunology and Molecular Genetic, Golnik, Slovenia
          878       The assessment of IL-4, IL-5, IL-10, TGF—β in whole-blood supernatants in patients with hymenoptera venom allergy during im-
                    munotherapy
                    Zakrzewski, A; Kruszewski, J; Dudziak, M; Tokarski, S
                    Military Institute of Medicine, Warsaw, Department of Infectious Diseases and Allergology, Warsaw, Poland
          879       The influence of 8-day rush venom specific immunotherapy (VIT) on baseline serum tryptase concentration in children
                    Cichocka-Jarosz, E1; Lis, G1; Rogatko, I2; Brzyski, P3; Jedynak-Wysowicz, U1; Pietrzyk, J1
                    1Jagiellonian University Medical College, Department of Pediatrics, Kraków, Poland; 2Jagiellonian University Medical College, Department of Clini-

                    cal Biochemistry, Kraków, Poland; 3Jagiellonian University Medical College, Chair of Epidemiology and Preventive Medicine, Kraków, Poland
          880       Safety and tolerability of venom immunotherapy with purified extracts in comparison with non-purified products. A randomi-
                    sed controlled multicentre trial in 94 patients
                    Bilò, B1; Severino, M2; Cilia, M3; Pio, A4; Casino, G5; Campodonico, P6; Milani, M6
                    1Ospedali Riuniti, Allergy Clinic, Ancona, Italy; 2Ospedale San Giovanni di Dio, Allergy Clinic, Florence, Italy; 3Ospedale Civile, Allergy Clinic, Locri,

                    Italy; 4Curteri Hospital, Mercato S. Severino, Allergy Clinic, Salerno, Italy; 5Presidio Ospedaliero Pié di Monte Matese, Allergy and Respiratory Opera-
                    tive Unit, Caserta, Italy; 6ALK Abellò, Medical Department, Lainate, Italy
          881       Safety of hymenoptera venom immunotherapy: our experience
                    Sporcic, Z; Milicic, A; Tadic, D; Subotic, M; Tucakovic Parabucki, D; Popovic Kuzmanovic, D; Drobnjak Tomasek, O
                    Clinical Hospital Center “Bezanijska kosa”, Allergology and Clinical Immunology, Belgrade, Serbia and Montenegro
          882       Apis venom allergy: anaphylaxis due to immunotherapy
                    Alonso-Llamazares, A; Lara, P; Castro, A; Borja-Segade, J; Gomez-Torrijos, E; Feo-Brito, F
                    General Hospital, Allergy section, Ciudad Real, Spain
          883       The sting challenge test in patients with hymenoptera immunotherapy treatment
                    Gálvez Lozano, J; Anguita Carazo, J; Mayorgas Costoya, R; Saenz de San Pedro Morera, B; Palacios Colom, L
                    Complejo Hospitalario de Jaén, Unidad de Alergología, Jaén, Spain
          884       Health related quality of life (HRQoL) in Polish children treated with specific venom immunotherapy (VIT): a multicenter study
                    Cichocka-Jarosz, E1; Tobiasz-Adamczyk, B2; Brzyski, P2; Lis, G1; Jedynak, U1; Pietrzyk, J1; Lange, J3; Zagórska, W3; Kulus, M3; Swiebocka, E4; Kaczmarski,
                    M4; Malaczyñska, T5; Swidzicka, O5; Klajna-Kraluk, B6; Brêborowicz, A7; Kycler, Z7
                    1Jagiellonian University Medical College, Department of Pediatrics, Kraków, Poland; 2Jagiellonian University Medical College, Chair of Epidemiology

                    and Preventive Medicine, Kraków, Poland; 3Medical University, Department of Children Pulmonology and Allergy, Warszawa, Poland; 4Medical Uni-
                    versity, Department of Pediatrics, Children’s Gastroenterol, Bialystok, Poland; 5Regional Center of Allergology, Pulmonology and Mucoviscidosis, Re-
                    gional Center of Allergology, Pulmonology and Mu, Gdañsk, Poland; 6Regional Center of Allergology, Pulmonology and Mucoviscidosis, Regional
                    Center of Allergology, Pulmonology and Mu, Gdañska, Poland; 7University of Medical Sciences, Department of Pneumonology, Allergology and
                    Clini, Poznañ, Poland

           SCIT: Clinical Aspects I                                                                                                                                Annex
          Chairpersons
          Peter Eng, Switzerland
          Giannis Paraskevopoulos, Greece
          885        Comparison of efficacy and safety of a depigmented tree pollen extract with placebo in patients with type-I allergic rhinocon-
                     junctivitis
                     Sager, A1; Emuzyte, R2
                     1LETI Pharma GmbH, Medical Dpt., Witten, Germany; 2Vilnius University Faculty of Medicine, Clinic of Children Diseases, Vilnius, Lithuania

          886        Effect of pretreatment with omalizumab with or without antihistamines on the tolerability of immunotherapy in patients with
                     asthma inadequately controlled with inhaled corticosteroids
                     Panahloo, Z1; Casale, T2; Massanari, M3; Nelson, H4; Busse, W5; Kianifard, F3; Geba, G3; Zeldin, R3
                     1
                       Novartis Horsham Research Centre, Development, Horsham, United Kingdom; 2Creighton University, Department Of Medicine, Omaha, United
                     States; 3Novartis Pharmaceuticals Corporation, US Medical, East Hanover, United States; 4National Jewish Health, Department of Medicine, Denver,
                     United States; 5University of Wisconsin School of Medicine, Allergy, Asthma and Immunology Clinic, Madison, United States
          887        Specific immunotherapy induces airways resistance improvement in asthmatic patients
                     Loureiro, G; Tavares, B; Pereira, C; Calado, G; Ribeiro, C; Machado, D; Chieira, C
                     Hospitais da Universidade de Coimbra, Immunoallergy Department, Coimbra, Portugal
          888        Efficacy of a rush immunotherapy with a depigmented polymerised extract of grass pollen assessed in an environmental chal-
                     lenge chamber
                     Biller, H1; Badorrek, P1; Hohlfeld, J1; Krug, N1; Sager, A2
                     1Fraunhofer Institute of Toxicology and Experimental Medicine, Clinical Airway Research, Hannover, Germany; 2LETI Pharma GmbH, Medical Dept.,

                     Witten, Germany
          889        Subcutaneous high dose hypoallergenic preparations in daily practice in more than 2,900 allergic subjects — effective, safe and
                     accepted by patients
                     Martin, E1; Thum-Oltmer, S1; Mussler, S1; Jaeschke, B2; Narkus, A3
                     1
                       Allergopharma Joachim Ganzer KG, Medical Service, Reinbek, Germany; 2Allergopharma Joachim Ganzer KG, Clincal Supply Management, Rein-
                     bek, Germany; 3Allergopharma Joachim Ganzer KG, Medical Department, Reinbek, Germany


           142      EAACI 2009 Final Programme                                                                                            www.congrex.com/eaaci2009
                                                                        Posters

890        Effective, well tolerated and accepted in daily practice: subcutaneous immunotherapy (SCIT) with aluminium hydroxide-adsor-




                                                                                                                                                                             POSTERS
           bed pollen extracts
           Martin, E1; Thum-Oltmer, S1; Mussler, S1; Jaeschke, B2; Narkus, A3
           1Allergopharma Joachim Ganzer KG, Medical Service, Reinbek, Germany; 2Allergopharma Joachim Ganzer KG, Clinical Supply Management, Rein-

           bek, Germany; 3Allergopharma Joachim Ganzer KG, Medical Department, Reinbek, Germany
891        Long-term follow-up of SCIT with a high-dose hypo-allergenic six-grass pollen preparation: a comparison with non-hyposensiti-
           sed patients
           Narkus, A1; Mussler, S2; Kettner, J3
           1Allergopharma Joachim Ganzer KG, Medical Department, Reinbek, Germany; 2Allergopharma Joachim Ganzer KG, Medical Service, Reinbek, Ger-

           many; 3Allergopharma Joachim Ganzer KG, Clinical Logistics, Reinbek, Germany
892        A high-dose hypo-allergenic mite preparation is effective in children with allergic asthma caused by house dust mite
           Rudert, M1; Kettner, J2; Narkus, A3
           1Allergopharma Joachim Ganzer KG, Clinical Trials, Reinbek, Germany; 2Allergopharma Joachim Ganzer KG, Clinical Logistics, Reinbek, Germany;
           3Allergopharma Joachim Ganzer KG, Medical Department, Reinbek, Germany

893        Maintenance dose as starting dose of immunotherapy with vaccines containing glutaraldehyde polymerised mite allergen ex-
           tracts
           Tubella, L1; López, T1; Casanovas, M2
           1Centro Médico Delfos, Servicio de Alergia, Barcelona, Spain; 2Inmunotek, S.L., Medical Department, Madrid, Spain

894        Grass pollen SIT in daily medical practice — Effectiveness of sublingual immunotherapy is comparable with subcutaneous treat-
           ment
           Sieber, J1; Shah-Hosseini, K2; Mösges, R2
           1Stallergenes GmbH, Medical Department, Kamp-Lintfort, Germany; 2University of Cologne, IMSIE, Cologne, Germany

895        A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy
           Schiappoli, M1; Ridola, E2; Senna, G1; Alesina, R3; Antonicelli, L4; Asero, R5; Costantino, M6; Longo, R7; Nettis, E8; Musarra, A9; Crivellaro, M10; Savi, E11;
           Massolo, A12; Passalacqua, G13
           1Verona General Hospital, Allergy Unit, Verona, Italy; 2University of Parma, Dept of Clinical Sciences, Parma, Italy; 3University of Pavia, Respiratory Di-

           seases, Pavia, Italy; 4Umberto Primo Hospital Ancona, Allergy and Respiratory Diseases, Ancona, Italy; 5San Carlo Clinic, Allergy Unit, Paderno Dug-
           nano, Italy; 6Poma Hospital, Allergy Unit, Mantova, Italy; 7National Healthcare, Allergy Unit, Tropea, Italy; 8University of Bari, Allergy and Clinical
           Immunology, Bari, Italy; 9National Healthcare, Allergy Unit, Reggio Calabria, Italy; 10University of Padua, Allergy Unit, Padua, Italy; 11Guglielmo Da
           Saliceto Hospital, Allergy Unit, Piacenza, Italy; 12Faculty of Veterinary Medicine, University of Calgary, Dept of Ecosystem and Public Health, Calgary,
           Canada; 13Genoa University, Allergy and Respiratory Diseases Clinic, DIMI, Genoa, Italy
896        Tolerance of cluster protocols for aeroallergen immunotherapy
           Ibanez, E; Calaforra, S; Diaz, M; Giner, A; Almero, R; Colomer, N; Lopez, R; Arminana, C; Hernandez, D
           Hospital La Fe, Allergy, Valencia, Spain
897        Quality of life benefits for patients with seasonal grass pollen-allergic rhinoconjunctivitis receiving ultra short course subcuta-
           neous immunotherapy (uSCIT) with MPL adjuvant
           Keith, P1; Amersdorffer, J2
           1McMaster University Medical Centre, Research, Hamilton, United States; 2Allergy Therapeutics, Research & Development, Worthing, United King-

           dom

 New Insights into Immunotherapy                                                                                                                               Annex
Chairpersons
Noel Rodriguez-Perez, Mexico
Revaz Sepiashvili, Russia
898       Bronchial incitement trial with acarid antigen and histamine in specific immunotherapy using two genders of vaccines following
          two years of treatment of children with atopic bronchial asthma
          Botulinska, E; Hofman, J
          Clinical Children Hospital, Allergology Out-Patients Department, Bialystok, Poland
899       Immediate adverse reactions to allergen immunotherapy
          Midyat, L1; Demir, E1; Gülen, F1; Karadeniz, C1; Can, D2; Tanaç, R1
          1Ege University, Faculty of Medicine, Pediatric Pulmonology-Allergy, Izmir, Turkey; 2Dr. Behçet Uz Hospital of Educational and Research of Children

          Diseases and Surgery Clinic of Pediatry, Pediatric Pulmonology-Allergy, Izmir, Turkey
900       “Koblenzer Schema”: Safety of the RUSH-SCIT
          Barac, S; Nebel, J; Jacob, R
          Central Armed Forces Hospital of Germany, Koblenz, ENT, Koblenz, Germany
901       “Koblenzer Schema” satisfaction of patients with RUSH-SCIT
          Nebel, J; Barac, S; Jacob, R
          Central Armed Forces Hospital of Germany, Koblenz, ENT, Koblenz, Germany
902       Specific immunotherapy for outpatients consulting for respiratory allergy symptoms — the French REALIS survey
          Migueres, M1; Fontaine, J2; Grosclaude, M3; Haddad, T4; Saint-Martin, F5; Crestani, B6
          1Saint-Jean Clinic, , Toulouse, France; 2Private Office, , Reims, France; 3Claude Bernard Center, , Lyon, France; 4Private Office, , Paris, France; 5Stallerge-

          nes SA, Medico-Marketing Department, Antony, France; 6Bichat Hospital, , Paris, France
903       Clinical and sensitisation profiles of outpatients consulting for respiratory allergy symptoms — the French REALIS survey
          Migueres, M1; Crestani, B2; Grosclaude, M3; Haddad, T4; Fontaine, J5; Saint-Martin, F6; Lhéritier-Barrand, M6
          1Saint-Jean Clinic, , Toulouse, France; 2Bichat Hospital, , Paris, France; 3Claude Bernard Center, , Lyon, France; 4Private Office, , Paris, France; 5Private

          Office, , Reims, France; 6Stallergenes SA, Medico-Marketing Department, Antony, France



www.congrex.com/eaaci2009                                                                                                 EAACI 2009 Final Programme               143
                                                                                       Posters

          904       Allergist and compliance to allergen immunotherapy: a survey on 325 Italian specialists
POSTERS




                    Frati, F1; Puccinelli, P1; Scurati, S1; Liuzzo, M2; Hilaire, C3; Incorvaia, C4
                    1Stallergenes, Medical Department, Milan, Italy; 2Stallergenes, Marketing Department, Milan, Italy; 3Stallergenes, General Manager, Milan, Italy; 4ICP

                    Hospital, Allergy/Pulmonary rehabiliation, Milan, Italy
          905       The clinical status of asthmatic patients allergic to house dust mites-changes after one year of specific immunotherapy
                    Pechlivanidis, T; Sichletidis, L
                    Medical School of Aristoteles Univercity of Thessaloniki, Greece, Pulmonological Clinic, Thessaloniki, Greece
          906       Characterisation of allergen profiles — an important precondition for a successful therapy of polyvalent sensitised allergics
                    Muehlmeier, G; Reinhardt, F; Maier, H
                    German Military Hospital Ulm, ENT, Ulm, Germany
          907       Compliance, tolerance and side effects of mini-containers unidose sublingual immunotherapy
                    Palma-Carlos, A
                    Clinical Allergy Immunology Center, CAIC, Allergology, Lisbon, Portugal
          908       Oral immunotherapy for prevention of new allergen sensitisation: a randomised controlled trial in twins
                    Kesornsukhon, N
                    Samutsakorn Hospital, Otorhinolaryngology, Samutsakorn, Thailand
          909       A rapid dosage schedule of sublingual immunotherapy with Olea europaea pollen: safety
                    Puente, Y1; Madariaga, B2; Roviralta Puente, C1; Daza Muñoz, J3; Almeda Llamas, E1; Garcia-Arevalo, J1
                    1Alergoclinica Virgen de Loreto, Allergy, Cordoba, Spain; 2Bial-Aristegui, I+D, Bilbao, Spain; 3Hospital Universitario Virgen Macarena, Allergy, Seville,

                    Spain
          910       Latex sublingual immunotherapy: safety and efficacy
                    Buyukozturk, S; Gelincik, A; Ozseker, F; Colakoglu, B; Dal, M
                    Istanbul University, Istanbul Faculty of Medicine, Internal Medicine, Division of Allergy, Istanbul, Turkey
          911       Significant increase in IgG(4) levels after SLIT grass treatment. A double-blind, placebo-controlled, multi-center study (TWIN
                    grasses study)
                    Peter, R1; Kleinjans, H2; Hecker, H3
                    1
                     Center for Vascular Surgery and Dermatology, Chair, Ulm-Blaustein, Germany; 2HAL Allergy BV, Medical Department, Leiden, The Netherlands;
                    3HAL Allergie GmbH, Medical Department, Düsseldorf, Germany



           Immunological Changes following Immunotherapy                                                                                                           Annex
          Chairpersons
          Rudolf Valenta, Austria
          Margitta Worm, Germany
          912       Biochemical characterisation of intact allergen extract vaccines and chemically modified allergoid vaccines containing house
                    dust mite
                    Henmar, H; Lund, L; Meno, K; Friberg, L; Bergmann, K; Karlshøj, I; Giselsson, A; Ferreras, M
                    ALK-Abelló A/S, Allergen Chemistry and Biotechnology, Hørsholm, Denmark
          913       Clinical efficacy and immunological mechanisms of sublingual and subcutaneous specific immunotherapy in asthmatic/rhinitis
                    children sensitised to house-dust-mite: an open randomised controlled study
                    Eifan, A; Akkoc, T; Yildiz, A; Keles, S; Tevetoglu, A; Izgi, A; Ozdemir, C; Bahceciler, N; Barlan, I
                    Marmara University Medical Faculty, Pediatric Allergy and Immunology, Istanbul, Turkey
          914       Nasal administration of CpG induces a local airway inflammation
                    Månsson, A1; Bachar, O1; Adner, M2; Cardell, L3
                    1Laboratory of Clinical and Experimental Allergy Researc, Otorhinolaryngology, Malmö, Sweden; 2Karolinska Institutet, The National Institute of En-

                    vironmental Medicine, Solna, Sweden; 3Karolinska Institutet, Department of Otorhinolaryngology, Huddinge, Sweden
          915       A microarray immunoassay for the detection of allergen component specific IgG4 antibodies
                    Elfverson, G1; Härlin, A1; Nystrand, M1; Kober, A1; Harwanegg, C2
                    1
                      Phadia AB, NE, Uppsala, Sweden; 2VBC-genomics, Research, Vienna, Austria
          916       Release of granzyme B (GzmB) from peripheral blood leukocytes in patients with hymenoptera venom allergy — effect of
                    venom immunotherapy
                    Klos, Z1; Kujawiak, M1; Chalubinski, M2; Kosinski, S3; Cieslak, M3; Smorawska, E3; Grzelak, A1; Kowalski, M2; Grzegorczyk, J1
                    1
                      Medical University of Lodz, Department of Laboratory Medical Immunology, Lodz, Poland; 2Medical University of Lodz, Department of Immuno-
                    logy, Rheumatology and Allergy, Lodz, Poland; 3Medical University of Lodz, Central Clinical Hospital, Lodz, Poland
          917       Abstract withdrawn
          918       Does allergen specific immunotherapy influence clinical chemistry and haematology laboratory parameters in adults?
                    Sprung, V1; Mussler, S2; Narkus, A3; Häfner, D1
                    1Allergopharma Joachim Ganzer KG, Clinical Trials, Reinbek, Germany; 2Allergopharma Joachim Ganzer KG, Medical Service, Reinbek, Germany; 3Al-

                    lergopharma Joachim Ganzer KG, Medical Department, Reinbek, Germany
          919       Changes of basophil activation parameters after specific sublingual immunotherapy. Preliminary studies
                    Potapinska, O1; Zawadzka-Krajewska, A2; Kotula, I1; Popko, K1; Kulus, M2; Wasik, M1; Demkow, U1
                    1Medical University of Warsaw, Dep of Lab Diag and Clin Imm of Dev Age, Warsaw, Poland; 2Medical University of Warsaw, Dep of Pediatric Pneu-

                    monology and Allergology, Warsaw, Poland
          920       Comparison of specific immunotherapy (SIT) with standardised house dust mite extract and inhaled corticosteroids (ICS) treat-
                    ment: the effect on clinical parameters and immunologic markers in asthmatic children
                    Xiang, L
                    Beijing Children’s Hospital, Asthma Center, Beijng, China


           144      EAACI 2009 Final Programme                                                                                           www.congrex.com/eaaci2009
                                                                   Posters

921       Sublingual immunotherapy (SLIT) induce systemic tolerance in naive mice




                                                                                                                                                                 POSTERS
          Brimnes, J; Rask, C; Naesborg, T; Urioste, S; Diemar, E; Lund, K
          ALK-Abello, Experimental Immunology, Hoersholm, Denmark
922       Efficacy of specific immunotherapy in allergic rhinitis patients sensitised to birch pollen
          Zukowski, S; Moniuszko, M; Kowal, K; Lenczewska, D; Bodzenta-Lukaszyk, A
          Medical University of Bialystok, Departament of Allergology and Internal Medicine, Bialystok, Poland
923       A microarray immunoassay for the detection of allergen component specific IgG antibodies
          Elfverson, G1; Härlin, A1; Nystrand, M2; Kober, A2; Harwanegg, C3
          1Phadia AB, NE, Uppsala, Sweden; 2Phadia AB, NE, Uppsala, Sweden; 3VBC-genomics, Research, Vienna, Austria

924       Grass allergen tablet immunotherapy in children induces IgG4 antibody and IgE-blocking responses similar to those seen in
          adults
          Bufe, A1; Henmar, H2; Gronager, P3; Durham, S4
          1Ruhr-University Bochum, Department of Experimental Pneumology, Bochum, Germany; 2ALK-Abelló, Allergen Chemistry & Biotechnology, Hors-

          holm, Danmark; 3ALK-Abelló, Global Research, Horsholm, Danmark; 4Imperial College and Royal Brompton Hospital, Section of Allergy and Clinical
          Immunology, London, United Kingdom
925       Immunological changes after treatment with a depigmented and polymerised allergenic extract of D. pteronyssinus and D. fari-
          nae
          Iraola, V1; Carnés, J1; Badiola, C2; Robinson, D1; García Robaina, J3
          1Laboratorios LETI S.L., R&D, Madrid, Spain; 2Laboratorios LETI S.L., Medical Department, Madrid, Spain; 3Hospital Virgen de la Candelaria, Servicio

          de Alergia, Tenerife, Spain
926       Up-regulation of the inhibitory FcγRIIb receptor on B cells with allergen in the offspring of immunised mothers
          Victor, J; Muniz, B; Brito, C; Fusaro, A; Duarte, A; Sato, M
          School of Medicine - USP, Dermatology, São Paulo, Brazil
927       Allergic response modulation by different adjuvants in a murine model of pollen allergy
          Vazquez de la Torre, M1; Zubeldia, J2; Higaki, Y2; Conejero, L2; La Rotta, A2; Baeza, M2
          1Hospital Infanta Leonor, Allergy Service, Madrid, Spain; 2Hospital Gregorio Marañón, Allergy Service, Madrid, Spain

928       Modulation of mitogen activated protein kinase activity during allergen immunotherapy
          Gawlik, R1; Jawor, B1; Rogala, B1; DuBuske, L2
          1Silesian University School of Medicine, Department of Allergy and Immunology, Zabrze, Poland; 2Immunology

          Research Institute of New England, Department of Allergy and Immunology, Gardner, MA, United States
929       Assessment of the efficacy of subcutaneous (SIT), sublingual (SLIT) and combined SIT and SLIT allergen immunotherapy in pati-
          ents with pollen allergy and cross-reacting food allergen sensitisation
          Romaniuk, A1; Romaniuk, L1; DuBuske, L2
          1Kiev Allergo Center, , Kiev, Ukraine; 2Immunology Research Institute of New England, Department of Allergy and Immunology, Gardner, MA, Uni-

          ted States

 From Bench to Bedside                                                                                                       The Congress Hall Foyer
Chairpersons
Consuelo Martínez Cócera, Spain
Uta Jappe, Germany
930       Prevalence and features of food allergy in adults
          Della Torre, F; Limonta, A; Della Torre, E
          INRCA, Pneumologic Department, Casatenovo (LC), Italy
931       Update on the Europrevall food allergen library: requirements for high quality allergens to improve in vitro diagnosis
          Hoffmann-Sommergruber, K1; Sancho, A2; Holzhauser, T3; Lidholm, J4; Marknell Dewitt, Å4; Skov, P5; Alessandri, S6; Lovegrove, A7; Marsh, J7; Neu-
          bauer, A8; Lauer, I3; Hofstetter, G9; Radauer, C9; Reese, G3; Fernández-Rivas, M10; Vieths, S3; Shewry, P7; Mills, C2
          1Medical University of Vienna, Dept. of Pathophysiology, Vienna, Austria; 2Institute of Food Research, IFR, Norwich, United Kingdom; 3Paul Ehrlich

          Institute, Division of Allergology, Langen, Germany; 4Phadia AB, Molecular Biology R&D, Uppsala, Sweden; 5The Reference Laboratory, The Refe-
          rence Laboratory, Copenhagen, Denmark; 6University of Florence, CERM, Florence, Italy; 7Rothamstead Research Ltd, Plant Science, Harpenden,
          United Kingdom; 8Biomay AG, Biomay AG, Vienna, Austria; 9Medical University of Vienna, Dept of Pathophysiology, Vienna, Austria; 10Hospital Cli-
          nico San Carlos, Allergy Department, Madrid, Spain
932       Food allergy plays an important role in PFAPA? Hypothesis based on clinical observation
          Cederblad, F; Nordvall, L
          Uppsala University Hospital, Department of Women and Childrens Health, Uppsala, Sweden
933       Impact of abiotic environmental factors on the allergenicity of carrots
          Dölle, S1; Schwarz, D2; Roß, D3; Ernst, D1; Lehmann, K3; Scheler, C3; Franken, P2; George, E2; Worm, M1
          1
            Charité - Universitätsmedizin Berlin, Department of Dermatology and Allergology, Berlin, Germany; 2Institute for Vegetable and Ornamental
          Crops, Institute for Vegetable and Ornamental Crops, Großbeeren, Germany; 3Proteome Factory, Proteome Factory, Berlin, Germany
934       Abstract moved to 1285b
935       Manufacturing of a margarine guaranteed as cow’s milk and peanut allergy-free
          Renaudin, J1; Morisset, M1; Astier, C2; Lemois, B3; Breton, S4; Bihain, B5; Kanny, G1; Jacquenet, S5
          1University Hospital, Internal Medicine,Clinical Immunology&Allergology, Nancy, France; 2Nancy University, ENSAIA, Vandoeuvre-Les-Nancy,

          France; 3St-Hubert SA, Quality Department, Ludres, France; 4St-Hubert SA, Department of Scientific Affairs, Ludres, France; 5Genclis SAS, Food Al-
          lergy Department, Vandoeuvre-Les-Nancy, France




www.congrex.com/eaaci2009                                                                                         EAACI 2009 Final Programme            145
                                                                                       Posters

          936      IgE-mediated cow’s milk protein allergy: clinical and immunological comparison between tolerant and allergic children
POSTERS




                   Pereira da Silva, S1; Paiva, M2; Pité, H2; Prates, S2; Matos, V3; Loureiro, V3; Leiria Pinto, P2
                   1Hospital Santa Maria, Immunoallergology, Lisbon, Portugal; 2Dona Estefânia Hospital, Immunoallergology, Lisbon, Portugal; 3Dona Estefânia Hos-

                   pital, Clinical Pathology Department, Lisbon, Portugal
          937      Uncommon food allergies and risk of asthma and anaphylaxis
                   Karakas, T; Soyer, O; Civelek, E; Sekerel, B; Tuncer, A; Kalayci, O; Sackesen, C
                   Hacettepe University, Faculty of Medicine, Pediatric Allergy and Asthma Unit, Ankara, Turkey
          938      Computerised identification of allergens in food ingredient descriptions
                   Roesch, N1; Arens, A1; Feidert, F2; Herbst, R1; Mösges, R3
                   1Centre de Recherche Public Henri Tudor, SANTEC (GA2LEN Collaborating Centre), Luxembourg, Luxembourg; 2Centre Hospitalier de Luxembourg,

                   ORL-Eich, Luxembourg, Luxembourg; 3University Hospital of Cologne, IMSIE, Cologne, Germany
          939      Usefulness of oral food challenge in eosinophilic esophagitis: case report
                   Valbuena, T1; Caballero, M2; Sánchez-Pastor, S2; Lucendo, A3; Pascual, C1; Fiandor, A2; Quirce, S2
                   1Hospital Infanta Sofía, Allergology, Madrid, Spain; 2Hospital La Paz, Allergology, Madrid, Spain; 3Hospital General Tomelloso, Gastroenterology, Ciu-

                   dad Real, Spain
          940      Walnut and or peanut allergy — clinical and laboratory patterns
                   Luz, S; Lopes, A; Spínola Santos, A; Costa, A; Santos, M; Pereira Barbosa, M
                   Santa Maria Hospital, Immunoallergology Department, Lisbon, Portugal
          941      Immediate and delayed food allergy in orofacial granulomatosis
                   Brostoff, J1; Patel, P1; Barone, F2; Nunes, C1; Odell, E3; Boursier, L2; Escudier, M4; Challacombe, S4; Spencer, J2; Sanderson, J1
                   1Kings College London, Nutritional Sciences Research Division, London, United Kingdom; 2Kings College London, Immunobiology, London, United

                   Kingdom; 3Kings College London, Pathology, London, United Kingdom; 4Kings College London, Oral Medicine, London, United Kingdom
          942      Evaluation of specific IgE antibodies to Ara h 1, Ara h 2, Ara h 3 and Ara h 8 as risk markers for severe allergic reactions to peanut
                   Movérare, R1; van Odijk, J2; Sjölander, S3; Poorafshar, M3; Ahlstedt, S4; Borres, M5; Bengtsson, U2
                   1Phadia AB and Uppsala University, Department of Medical Sciences, Respiratory Medicine and Allergology, Uppsala, Sweden; 2Sahlgrenska Aca-

                   demy at Göteborg University, Department of Respiratory Medicine and Allergology, Gothenburg, Sweden; 3Phadia AB, R&D, Uppsala, Sweden; 4Ka-
                   rolinska Institutet, National Institute of Environmental Medicine, Experimental Asthma and Allergy Research, Stockholm, Sweden; 5Phadia AB and
                   Sahlgrenska Academy at Göteborg University, Department of Pediatrics, Uppsala and Gothenburg, Sweden
          943      Life-threatening anaphylaxis in an adult patient monosensitised to almond: a case report
                   García Sifuentes, L1; Pastor, C2; Nuñez Acevedo, B1; Vásquez Cortés, S1; Martínez Cócera, C1; Fernández-Rivas, M1
                   1Hospital Clínico San Carlos, Allergy Deparment, Madrid, Spain; 2Fundación Jimenez Díaz, Immunology Deparment, Madrid, Spain

          944      Allergy to oyster
                   Ciano Albanese, M; Lombardo, G; Arena, E; Ventura Spagnolo, T; Tigano, V; Gangemi, S
                   School and Division of Allergy and Clinical Immunology, Department of Human Pathology, Messina, Italy
          945      The profile of gliadin-degrading activity of duodenal mucosa points to a role of microflora in celiac disease
                   Bernardo, D1; Vallejo-Diez, S1; Martinez-Abad, B1; Montalvillo, E1; Calvo, C2; Fernández-Salazar, L3; Garrote, J4; Arranz, E5; Blanco-Quiros, A6
                   1University of Valladolid, Immunology. IBGM, Valladolid, Spain; 2Hospital Clínico Universitario, Pediatrics, Valladolid, Spain; 3Hospital Clínico Universi-

                   tario, Gastroenterology Unit, Valladolid, Spain; 4Hospital Clínico Universitario, Immunology, IBGM, Valladolid, Spain; 5University of Valladolid, Immu-
                   nology, IBGM, Valladolid, Spain; 6University of Valladolid, Pediatrics, IBGM, Valladolid, Spain
          946      Specific oral tolerance induction in children with IgE mediated persistent egg’s allergy
                   Fuentes, V; Gacias, L; Zapatero, L; Alonso, E
                   Sección de Alergia Infantil. Hospital Materno-infantil Gregorio Marañón, Allergy, Madrid, Spain
          947      Food allergy to sturgeon caviar with an occupational twist
                   Johnsen, C1; Skov, P2
                   1National University Hospital, Allergy Unit, Copenhagen, Denmark; 2RefLab, Laboratory Department, Copenhagen, Denmark

          948      Factors related to positive outcome of double-blind placebo-controlled food challenges in egg allergic children
                   Rodriguez del Rio, P1; Vázquez-Cortés, S1; Barreales Tolosa, L2; Reig Rincon de Arellano, I2; Martinez-Cocera, C2; Fernández-Rivas, M2
                   1Hospital Clinico San Carlos, Allergy, Madrid, Spain; 2Hospital Clinico San Carlos, Epidemiology, Madrid, Spain

          949      Multiple food allergy - case report
                   Antunes, J; Borrego, M; Pinto, P
                   Hospital Dona Estefânia, Immunoallergy Department, Lisbon, Portugal

           Identification of New Allergens in Food                                                                                        The Congress Hall Foyer
          Chairpersons
          Beatrice Jahn-Schmid, Austria
          Christof Nekam, Hungary
          950        Clinical usefulness of quantitative evaluation of egg antigen in food and egg specific IgG4 antibody in serum
                     Ito, S
                     Doshisha Women’s College of Liberal Arts, Food Science and Mutrtion, Kyoto, Japan
          951        Allergy to quail egg without cross-reactivity to chicken egg
                     Amo, A; Carretero-Anibarro, P; Juste, S; Iparraguirre-Castro, A; Blanco-Carmona, J
                     Complejo Asistencial de Burgos, Allergy Department, Burgos, Spain
          952        Allergy to goat’s and sheep’s milk: identification of allergenic proteins
                     Cases, B1; García-Ara, C2; Teresa, B2; Perez-Gordo, M1; Pastor, C1; Vivanco, F1; Quirce, S2
                     1Fundacion Jimenez Diaz, Allergy, Madrid, Spain; 2Hospital Universitario La Paz, Allergy, Madrid, Spain




          146      EAACI 2009 Final Programme                                                                                             www.congrex.com/eaaci2009
                                                               Posters

953    The Bet v 1 scaffold is inherently unstable to low pH and proteolysis




                                                                                                                                                             POSTERS
       Sancho, A1; Wangorsch, A2; Jensen, B3; Johnson, P1; Watson, A1; Alexeev, Y1; Reese, G2; Ballmer-Weber, B4; Stahl Skov, P3; Hoffmann-Sommergruber,
       K5; Vieths, S2; Mackie, A1; Mills, C1
       1Institute of Food Research, Food Structure and Health, Norwich, United Kingdom; 2Paul-Ehrlich-Institut, Allergy Department, Langen, Germany;
       3The Reference Laboratory, Department 7512, Copenhagen, Denmark; 4University Hospital, Zurich, Dermatology Department, Zurich, Switzerland;
       5
         Medical University of Vienna, Pathophysiology Department, Vienna, Austria
954    Validation of a Spanish language version of the self-administered food allergy quality of life questionnaire for adults (FAQLQ-
       AF)
       Antolin, D1; Cerecedo, I2; Muriel, A3; Cano, A3; Dieguez, M2; Zamora, J3; Flokstra-de Blok, B4; Dubois, A4; Abraira, V3; De la Hoz Caballer, B1
       1Hospital Ramon y Cajal, Allergy Department, Madrid, Spain; 2Hospital del Sureste, Allergy Unit, Arganda del Rey (Madrid), Spain; 3Hospital Ramon

       y Cajal, Unidad de Bioestadística Clínica - CIBERESP, Madrid, Spain; 4University Medical Center Groningen, Paediatric Allergy and Paediatric Pulmo-
       nology, Groningen, The Netherlands
955    Differences between clinical history, specific IgE and skin prick tests in the diagnosis of food allergy
       Sakellariou, A; Zannikos, K; Sinaniotis, A; Vassilopoulou, E; Saxoni-Papageorgiou, P; Papadopoulos, N
       Allergy Research Laboratories, 2nd Pediatric Dpt. Athens University, Athens, Greece
956    New hydrolised formulas in infants suffering from severe milk allergy
       Menna, G
       ISS Security Social Institute, Pediatrics, Borgo Maggiore, San Marino
957    Clinical characteristics of patients with banana allergy
       Cakcak, B; Celmeli, F; Bingol Boz, A
       Akdeniz University Faculty of Medicine, Pediatrics, Antalya, Turkey
958    Evaluation of the effect of NSAID’s on skin reactivity in patients with a history of anaphylaxis related to food and NSAID’s
       De la Cruz, I; Ibanez, E; Calaforra, S; Colomer, N; Diaz, M; Reyes, J; Hernandez, D
       Hospital La Fe, Allergy, Valencia, Spain
959    Pro/prebiotics in products for infants with cow’s milk allergy
       Makarova, S1; Borovick, T1; Netrebenko, O2
       1Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Children Nutrition Department, Moscow, Russian Federation; 2Russian

       Medical Univercity, Pediatry Department, Moscow, Russian Federation
960    Food hypersensitivity in a random adult population in R. Macedonia
       Mijakoski, D1; Karadzinska-Bislimovska, J2; Stoleski, S2; Minov, J2; Marsenic, M1; Ezova, N1; Risteska-Kuc, S3; Milkovska, S1
       1Institute of Occupational Health-WHO Collaborating Center, GA2LEN Collaborating Center, Skopje, R. Macedonia, Allergy Center, Skopje, Macedo-

       nia, Fyrom; 2Institute of Occupational Health-WHO Collaborating Center, GA2LEN Collaborating Center, Skopje, R. Macedonia, Dpt for Cardiorespi-
       ratory Functional Diagnostics, Skopje, Macedonia, Fyrom; 3Institute of Occupational Health-WHO Collaborating Center, GA2LEN Collaborating
       Center, Skopje, R. Macedonia, Dpt for Occupational Diseases, Skopje, Macedonia, Fyrom
961    Soy reactions in Japanese adults sensitised to Gly m 4 and alder pollen
       Sjölander, S1; Urisu, A2; Ido, T3; Yagami, A4; Fukuda, K5; Horikawa, T6; Iijima, S7; Tanaka, A8; Borres, M9; Poorafshar, M1
       1Phadia AB, R&D, Uppsala, Sweden; 2Fujita Health University, Department of Pediatrics, Nagoya, Japan; 3University of Fukui, Department of Derma-

       tology, Fukui, Japan; 4Fujita Health University, Department of Dermatology, Aichi, Japan; 5Surugadai Nihon University Hospital, Department of Der-
       matology, Tokyo, Japan; 6Kobe University, Department of Clinical and Molecular Medicine, Hyogo, Japan; 7Mito Saiseikai General Hospital,
       Department of Dermatology, Ibaraki, Japan; 8Phadia AB, KK, Tokyo, Japan; 9Göteborg University and Phadia AB, Medical Faculty, Gothenburg/Upp-
       sala, Sweden
962    Ara h 2 predicts clinical reactivity to peanuts in Japanese peanut sensitised subjects
       Holmquist, I1; Komata, T2; Tanaka, A3; Lindbäck, J4; Poorafshar, M1; Ebisawa, M5
       1
         Phadia AB, R&D, Uppsala, Sweden; 2Sagamihara National Hospital, Department of Pediatrics, Kanagawa, Japan; 3Phadia KK, R&D, Tokyo, Japan;
       4Phadia AB, Biomectrics, Uppsala, Sweden; 5Sagamihara National Hospital, Clinical Reseach Center Allergology Rheumatology, Kanagawa, Japan

963    Lactose free partially hydrolised milk formula improves infantile colic
       Xinias, I; Mavroudi, A; Pampouka, M; Demertzidou, V; Ourailoglou, O
       Hippokration Hospital of Thessaloniki, 3rd Paediatric Department, Thessaloniki, Greece
964    Which protein is the most important allergen in cow’s milk?
       Shokouhi Shoormasti, R1; Kalantari, N2; Pourpak, Z1; Lebaschi, Z1; Fazlollahi, M1; Movahedi, M1; Baghian, S2; Moin, M1
       1
         Immunology, Asthma and Allergy Research Institute, Tehran Univerisity of Medical Sciences, Tehran, Islamic Republic of Iran; 2Department of Im-
       munology and Allergy, Tehran Univerisity of Medical Sciences, Tehran, Islamic Republic of Iran
965    A standardised challenge vehicle for the diagnosis of food allergy and threshold studies
       Salt, L1; Adel-Patient, K2; Blanc, F2; Cochrane, S3; Crevel, R3; Rogers, A4; Coutts, J4; Mackie, A1; Mills, C5
       1Institute of Food Research, Food Structure, Norwich, United Kingdom; 2Laboratoire Inra, Immuno-Allergie Alimentaire, Gif-sur-Yvette, France; 3Uni-

       lever, Safety & Environmental Assurance Centre, Bedfordshire, United Kingdom; 4Tepnel Research Products and Services, Food Safety Division,
       Flintshire, United Kingdom; 5Institute of Food Research, Food Structure, Norwich, United Kingdom
966    The role of peanut specific IgE, IgG and IgG4 levels in the diagnostic procedure of peanut allergy
       Camargo L. de Oliveira, L; Schulz, G; Niggemann, B; Wahn, U; Beyer, K
       Children’s Hospital Charité, Department of Pediatric Pneumology and Immunology, Berlin, Germany
967    Specific oral tolerance induction for milk allergy
       Farmakas, N; Piskou, K; Douladiris, N; Manousakis, M; Papadopoulos, N
       Kapodistrian University, Allergy Department 2nd Pediatric Clinic, Athens, Greece
968    Food processing affects the immunogenic and allergenic potential of peanut and soy allergens in an oral rat model
       Kroghsbo, S1; Rigby, N2; Mackie, A2; Mills, C2; Salt, L2; Bogh, K3; Madsen, C3
       1National Food Institute, Technical University of Denmark, Department of Toxicology and Risk Assessment, Copenhagen, Danmark; 2Institute of

       Food Research, Biochemistry, Norwich, United Kingdom; 3National Food Institute, Technical University of Denmark, Department of Toxicology and
       Risk Assessment, Copenhagen, Denmark

www.congrex.com/eaaci2009                                                                                    EAACI 2009 Final Programme             147
                                                                                    Posters

          969       Apples as a cause of recurrent angioneuroticum oedema of the upper lip not associated with birch pollen allergy - a case report
POSTERS




                    Slaweta, G1; Klos, K2; Kruszewski, J2
                    1Allergy Outpatient Clinic, Kielce, Poland; 2Military Institute of Medicine, Department of Infectious Diseases and Allergology, Warsaw, Poland



           Allergens II                                                                                                              The Congress Hall Foyer
          Chairpersons
          Oscar Palomares, Spain
          Ulf Darsow, Germany
          970       The pollinosis in Algiers
                    Gharnaout, M; Douagui, H
                    Hospital, Pneumology-Allergology and Thoracic Oncology, Algiers, Algeria
          971       Harvesting pollen in Algiers
                    Gharnaout, M; Douagui, H
                    Hospital, Pneumology-Allergology and Thoracic Oncology, Algiers, Algeria
          972       Pollen grains in the atmosphere of Konya, Turkey
                    Kizilpinar, I1; Artac, H2; Pekcan, S2; Dogan, C1; Reisli, I2
                    1Hacettepe University, Faculty of Science, Department of Biology, Ankara, Turkey; 2Selcuk University Meram Medical Faculty, Department of Pediat-

                    ric Immunology and Allergy, Konya, Turkey
          973       Identification and characterisation of pollen allergens in two cypress species by IEF, SDS-PAGE and immunoblotting
                    Shahali, Y1; Sutra, J1; Desvaux, F2; Peltre, G1; Calleja, M3; Charpin, D4; Senechal, H5; Poncet, P6
                    1Laboratory of Environment and Analytical Chemistry, ESPCI, Paris, France; 2Laboratory of Environment and Analytical Chemistry, ESPCI; Pierre and

                    Marie Curie University (UPMC), Paris, France; 3Ecole Nationale Superieure d’Agronomie de Montpellier, -, Montpellier, France; 4Chest Diseases and
                    Allergy Department, Hopital Nord, Marseille, France; 5Laboratory of Environment and Analytical Chemistry, ESPCI; Inserm, Paris, France; 6Laboratory
                    of Environment and Analytical Chemistry, ESPCI; Institut Pasteur, Paris, France
          974       Identification of clinically relevant shared allergenic components from two common and dominant pollen taxa of Fabaceae,
                    from Calcutta, India
                    Mandal, J1; Roy, I2; Gupta-Bhattacharya, S1
                    1Bose Institute, Botany, Calcutta, India; 2Institute of Child Health, Allergy Department, Calcutta, India

          975       Prevalence and clinical relevance of hypersensitivity to pollen pan-allergens (polcalcin and Profilin): a SPT study
                    Asero, R1; Jimeno, L2; Barber, D2
                    1Clinica San Carlo, Ambulatorio di Allergologia, Paderno Dugnano, Italy; 2ALK-Abello, Departamento I + D, Madrid, Spain

          976       Is sensitisation to cat and dog relevant?
                    Ribeiro, F; Carrapatoso, I; Geraldes, L; Sousa, N; Machado, D; Chieira, C
                    Coimbra University Hospital, Immunoallergology Department, Coimbra, Portugal
          977       Prevalence of common mold allergy in patients with allergic rhinitis in Singapore
                    Ng, L; Hwang, S
                    Changi General Hospital, Otolaryngology, Singapore, Singapore
          978       Prevalence of latex allergy in high risk children
                    Yazdanpanah, S1; Nabavizadeh, H2
                    1Shiraz University, Public Health, Shiraz, Islamic Republic of Iran; 2Emam Sajad Hospital, Pediatrics, Yasuj, Islamic Republic of Iran

          979       Abstract withdrawn
          980       Sensitisation to house dust mites in adults with asthma and allergic rhinitis in Singapore
                    Phua, G1; Koh, M2; Tan, L1; Chan, P1
                    1
                      Singapore General Hospital, Respiratory and Critical Care Medicine, Singapore, Singapore; 2Singapore, Respiratory and Critical Care Medicine,
                    Singapore, Singapore
          981       Shrimp hypersensitivity and Dermatophagoides pteronyssinus cross-reactivity. Which proteins are involved?
                    Carrapatoso, I1; Cunha, R2; Rodrigues, F2; Geraldes, L1; Sousa, N1; Todo-Bom, A1; Chieira, C1
                    1
                      Coimbra University Hospital, Immunoallergology Department, Coimbra, Portugal; 2Coimbra University Hospital, Immunology Laboratory, Co-
                    imbra, Portugal
          982       Study of psocoptra as a new in-door allergen in comparison to house dust, mites and molds
                    Abo-ali, F; Ashor, Z; Atia, M; Refaat, M
                    Faculty of medicine. Ain Shams University, Allergy, Clinical Immunology, Cairo, Egypt
          983       The IgE cross-reactivity between house dust mites and storage mites in patients from Guangzhou city
                    Zhang, C1; Gjesing, B2; Lai, X2; Li, J1; Spangfort, M2; Zhong, N3
                    1Guangzhou Institute of Respiratory Diseases, Allergy Department, Guangzhou, China; 2ALK-Abelló, Asia Pacific Research, Hong Kong, China; 3Gu-

                    angzhou Institute of Respiratory Diseases, Respiratory Department, Guangzhou, China
          984       Profile of group 1 and group 2 allergens in growing cultures of Dermatophagoides farinae
                    Poola, S; Arlian, L; Morgan, M
                    Wright State University, Department of Biological Sciences, Dayton, Ohio, United States
          985       Do other factors in bedding dust affect sensitisation to house dust mites? An in vivo study using subjects’ own bedding dust
                    Smith, C1; Stanley, T2; Siebers, R3; Crane, J4
                    1University of Otago Wellington School of Medicine, Medical Student, Wellington, New Zealand; 2University of Otago Wellington School of Medi-

                    cine, Paediatrics, Wellington, New Zealand; 3University of Otago Wellington School of Medicine, Medicine (WARG), Wellington, New Zealand; 4Uni-
                    versity of Otago Wellington School of Medicine, Wellington Asthma Research Group, Wellington, New Zealand




           148      EAACI 2009 Final Programme                                                                                       www.congrex.com/eaaci2009
                                                                       Posters

986        Allergen sensitivity in a multi-ethnic tropical Asian community




                                                                                                                                                                          POSTERS
           Koh, M; Phua, G; Tan, L; Chan, P
           Singapore General Hospital, Respiratory and Critical Care Medicine, Singapore, Singapore

 Autoimmunity and Immunodefiencies                                                                                                 The Congress Hall Foyer
Chairpersons
Jenny Hughes, United Kingdom
Luigi Fontana, Italy
987       A novel approach of T cell modulation in the acute phase of persistent herpes virus infection
          Rudenko, M1; Simbirtsev, A2; Rudenko, I1; Zabelev, A1; Shemshura, A3
          1Clinical Center Eurodon, , Rostov-on-Don, Russian Federation; 2The State Scientific Center State Research Institute of Highly Pure Biopreparations, ,

          Saint Petersburg, Russian Federation; 3Rostov Research Institute of Microbiology and Parasitology, , Rostov-on-Don, Russian Federation
988       Impaired Th17 differentiation is a common attribute of genetically distinct forms of the hyper IgE syndrome in a cohort of Tur-
          kish children
          Al-Khatib, S1; Keles, S2; Karakoc-Aydiner, E2; Reisli, I3; Camcioglu, Y4; Somer, A5; Yilmaz, M6; Ikinciogullari, A7; Kutukculer, N8; Yegin, O9; Kucukosma-
          noglu, E10; Genel, F11; Baki, A12; Yuksek, M13; Aytekin, C14; Bahceciler, N2; Lloret, M1; McGhee, S1; Barlan, I2; Chatila, T1
          1
            University of California at Los Angeles, David Geffen School of Medicine, Pediatric Immunology, Allergy and Rheumatology, Los Angeles, United
          States; 2Marmara Medical School, Pediatric Allergy and Immunology Department, Istanbul, Turkey; 3Selcuk University, Pediatric Allergy and Immu-
          nology Department, Konya, Turkey; 4Istanbul University, Cerrahpasa Medical School, Pediatric Allergy and Immunology Department, Istanbul, Tur-
          key; 5Istanbul University, Istanbul Medical School, Pediatric Infection and Immunology Department, Istanbul, Turkey; 6Cukurova University,
          Pediatric Allergy and Immunology Department, Adana, Turkey; 7Ankara University, Pediatric Allergy and Immunology Department, Ankara, Turkey;
          8
            Ege University, Pediatrics Department, Izmir, Turkey; 9Akdeniz University, Pediatric Immunology Department, Antalya, Turkey; 10Gaziantep Univer-
          sity, Pediatric Allergy Department, Gaziantep, Turkey; 11Behcet Uz State Hospital, Pediatric Immunology Department, Izmir, Turkey; 12Karadeniz
          Technical University, Pediatric Allergy Department, Trabzon, Turkey; 13Zeynep Kamil State Hospital, Pediatric Immunology Department, Istanbul,
          Turkey; 14Sami Ulus State Hospital, Pedaitric Immunology Department, Ankara, Turkey
989       Clinical characterisation and EUROclass classification in a common variable vmmunodeficiency cohort
          Pereira da Silva, S1; Lopes da Silva, S1; Barbosa, R2; Alves, R1; Pedro, E1; Albuquerque, A2; Melo, A2; Santos, M2; Pereira Barbosa, M1; M. Victorino, R2; E.
          Sousa, A2
          1Hospital de Santa Maria, Imunoalergologia, Lisboa, Portugal; 2Instituto de Medicina Molecular/ Faculdade de Medicina de Lisboa, Unidade de

          Imunologia Clínica, Lisboa, Portugal
990       Association between clinical and immunological patterns in 12 CVID patients
          Sousa, N1; Faria, E1; Calado, G1; Geraldes, L1; Coelho, A2; Pais, L2; Chieira, C1
          1Coimbra University Hospitals, Imunoallergology Department, Coimbra, Portugal; 2Central Histocompatibility Center, Flow cytometry Laboratory,

          Coimbra, Portugal
991       Screening of Bruton’s tyrosine kinase deficiency by short tandem repeat profiling as an indirect simple detection method
          Nasseri, S1; Aghamohammadi, A2; Houshmand, M3; Zahedi, S2; Pourpak, Z2; Moin, M2
          1Immunology, Asthma & Allergy Research Institute, Tehran University of Medical Sciences, Genetics Department, Tehran, Islamic Republic of Iran;
          2Immunology, Asthma & Allergy Research Institute, Tehran University of Medical Sciences, Immunology Department, Tehran, Islamic Republic of

          Iran; 3Special Medical Center, Medical Genetics Department, Tehran, Islamic Republic of Iran
992       Cardiovascular risk profile in juvenile systemic lupus erythematosus patients
          Sousa, H1; Martins, V2; Gonzaga, D1; Matos, P3; Guedes, M4
          1Hospital de santo antonio, Pediatrics, porto, Portugal; 2Centro Hospitalar de Vila Real, Pediatrics, Vila Real, Portugal; 3Hospital de santo antonio, Pe-

          diatrics-nephrology, porto, Portugal; 4Hospital de santo antonio, Pediatrics-immunology, porto, Portugal
993       Pathogenic role of CD4+ IL-4+ cytotoxic T cells in Churg-Strauss syndrome
          Guida, G1; Martinuzzi, E2; Cignetti, A3; Sciascia, S1; Boita, M3; Circosta, P3; Heffler, E1; Rolla, G1; Mallone, R2
          1
            University of Torino, Allergy and Clinical Immunology, Torino, Italy; 2Université Paris Descartes - Paris V, INSERM U561, Paris, France; 3IRCC, Labora-
          tory of Tumor Immunology, Candiolo (TO), Italy
994       Distinctive cells of the native and adaptive immune system with regulatory properties in patients with Sjögren’s syndrome
          Papp, G; Szodoray, P; Zeher, M
          3rd Dept. of Int. Medicine, Medical and Health Science Center, University of Debrecen, Clinical Immunology, Debrecen, Hungary
995       Lupus anticoagulans and antiphospholipid syndrome: clinical relevance of different assay tests
          Sciascia, S1; Bertero, M1; Kuzenko, A1; Guida, G1; Heffler, E1; Pizzimenti, S1; Badiu, I1; Cosseddu, D2
          1
            University of Torino - AO Mauriziano, Allergy and Clinical Immunology, Turin, Italy; 2AO Mauriziano “Umberto I”, Analysis Laboratory, Turin, Italy
996       CD55 and CD59 in autoimmune disease
          Belizna, C1; Hamidou, M2; Levesque, H3
          1CHU Rouen, Internal Medicine, Rouen, France; 2CHU Nantes, Internal Medicine, Nantes, France; 3CHU Rouen, Internal Medicine, Bois Guillaume,

          France
997       Bone remodelling in psoriatic arthritis versus rheumatoid arthritis
          Ciacli, C
          Vasile Goldis’ West University, Department of Immunology, Arad, Romania




www.congrex.com/eaaci2009                                                                                               EAACI 2009 Final Programme               149
                                                                                        Posters
POSTERS




           Immunodeficiencies II                                                                                                           The Congress Hall Foyer
          Chairpersons
          Yildiz Camcioglu, Turkey
          Janne Björkander, Sweden
          998       Four novel mutations in Wiskott-Aldrich disease
                    Safaei, S1; Pourpak, Z1; Hoseinipour Rafati, A1; Houshmand, M2; Moin, M1
                    1
                     Immunology, Asthma and Allergy Research Institute, Children’s Medical Center, Tehran, Islamic Republic of Iran; 2Department of Medical Genetic,
                    Special Medical Center, Tehran, Islamic Republic of Iran
          999       Human herpes viruses infection in a group of children
                    Markova, T1; Tchouvirov, D1; Kozhinova, E2
                    1Advanced Study Institute of Federal Medico-Biological Agency, Clinical Immunology and Allergology, Moscow, Russian Federation; 2Institute of

                    Immunology of Federal Medico-Biological Agency, Clinical Immunology and Allergology, Moscow, Russian Federation
          1000      Mutation analysis of the NCF1 gene in chronic granulomatous disease patients with the P47-phox deficiency in Iran
                    Fattahi, F1; Pourpak, Z1; Badalzadeh, M1; Movahedi, M2; Fazlollahi, M1; Mansouri, S3; Behmanesh, F4; Hamidieh, A5; Zandieh, F1; Bemanian, M1; Moin,
                    M1
                    1Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran; 2Department of Im-

                    munology and Allergy, Children’s Medical Center, Tehran, Islamic Republic of Iran; 3Division of Infectious Diseases and Clinical Immunology, Shahid
                    Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran; 4Department of Pediatrics, Mashhad University of Medical Sciences,
                    Mashhad, Islamic Republic of Iran; 5Department of Pediatric Hematology/Oncology, Shariati Hospital, Tehran, Islamic Republic of Iran
          1001      Neutrophil dysfunction in patients with beta-thalassemia major
                    Ghaffari, J; Vahidshahi, K; Kosarian, M; Karami, H; Mahdavi, M; Parvinnejad, N
                    Boali Hospital, Thalassemia Research Center, Sari, Islamic Republic of Iran
          1002      New mutations in the RAG1 gene in SCID patients
                    Safaei, S1; Pourpak, Z1; Houshmand, M2; Moin, M1
                    1Immunology, Asthma and Allergy Research Institue, Children’s Medical Center, Tehran, Islamic Republic of Iran; 2Special Medical Center, Depart-

                    ment of Medical Genetic, Tehran, Islamic Republic of Iran
          1003      Response to G-CSF (Granulocyte Colony-Stimulating Factor) and its side effects in patients with congenital neutropenia
                    Salehi, T1; Pourpak, Z2; Nayebpour, M3; Fazlollahi, M4; Alizadeh, Z5; Eshghi, P6; Chavosh Zadeh, Z7; Moin, M8
                    1Immunology, Asthma and Allergy Research Institute, Immunolgy Department, Tehran, Islamic Republic of Iran; 2Immunology, Asthma and Allergy

                    Research Institute, Immunology and Allergy, Tehran, Islamic Republic of Iran; 3Tehran University of Medical Sciences, Department of Pharmacology,
                    Tehran, Islamic Republic of Iran; 4Immunology, Asthma and Allergy Research Institute, Allergy and Immunology, Tehran, Islamic Republic of Iran;
                    5Immunology, Asthma and Allergy Research Institute, Department of Immunology, Tehran, Islamic Republic of Iran; 6Mofid Children Hospital, De-

                    partment of Pediatric Hematology and Oncology, Tehran, Islamic Republic of Iran; 7Mofid Children Hospital, Department of Immunology, Tehran,
                    Islamic Republic of Iran; 8Immunology,Asthma and Allergy Research Institute, Department of Allergy and Immunology, Tehran, Islamic Republic of
                    Iran
          1004      Seronegative status in babies who were born by women seropositive for HIV
                    Ilyinskaya, I
                    National Institute on Phtysiology & Pulmonology named by F.G. Yanovsky AMS of Ukraine, Laboratory of immunology, Kiev, Ukraine
          1005      The influence of cardiosurgery procedures on cellular immunity parameters in children with congenital heart defects
                    Cywinska-Bernas, A1; Pasnik, J1; Moll, J2; Moll, J3; Sysa, A2; Banasik, M4; Zeman, K1
                    1Medical University of Lódz, Department of Pediatrics and Clinical Immunology, Lódz, Poland; 2Institute of Polish Mother’s Health, Department of

                    Pediatric Cardiology, Lódz, Poland; 3Institute of Polish Mother’s Health, Department of Cardiosurgery, Lódz, Poland; 4Institute of Polish Mother’s He-
                    alth, Department of Clinical Immunology, Lódz, Poland
          1006      Chronic monoarticular arthritis and eczematous skin rash as initial manifestations of primary agammaglobulinemia
                    Momen, T
                    Nemazee Hospital, Pediatric Allergy & Immunology, Shiraz, Islamic Republic of Iran
          1007      Clinical surveillance program of pediatric hereditary angioedema (HAE) patients undergoing home treatment
                    Martinez-Saguer, I; Rusicke, E; Aygören-Pürsün, E; Klingebiel, T; Kreuz, W
                    J-W. Goethe University Hospital, Department of Peadiatrics, Frankfurt, Germany
          1008      Common variable immunodeficiency
                    Douagui, H; Gharnaout, M
                    Hospital, Allergology & Pneumology, Algiers, Algeria
          1009      Psoriatic arthritis and common variable immunodeficiency
                    Salgado, M1; Marques, S2; Vinhas, A1; Tomaz, E1; Pedroso, E2; Inácio, F1
                    1
                     Centro Hospitalar de Setubal, EPE, Immunoallergology, Setúbal, Portugal; 2Centro Hospitalar de Setubal, EPE, Internal Medicine, Setúbal, Portugal
          1010      Early detection of gastric adenocarcinoma in a patient with common variable immunodeficiency
                    D’Orio, C1; Spadaro, G2; Galdiero, M2; Siani, M2; Marone, G2; Genovese, A2
                    1University of Naples, Clinical Immunology and Allergy, Naples, Italy; 2University of Naples “Federico II”, Clinical Immunology and Allergy, Naples, Italy



           Inflammatory Cells and Mediators II                                                                                             The Congress Hall Foyer
          Chairpersons
          Shaoheng He, China
          Igor Kaidashev, Russia
          1011      Age-related peculiarities of eosinophil cationic protein levels in the serum of atopic and nonatopic patients
                    Sergeev, A1; Mustaphaeva, D2; Mokronosova, M1
                    1ENT Federal Center, Laboratory of Immunology, Moscow, Russian Federation; 2ENT Federal Center, Otorhinolaryngology Department, Moscow,

                    Russian Federation

           150       EAACI 2009 Final Programme                                                                                           www.congrex.com/eaaci2009
                                                                Posters

1012   Allelic variation in the human and mouse genes that encode mast cell-restricted tetramer-forming tryptases




                                                                                                                                                                POSTERS
       DuBuske, I; Wang, X; Stevens, R
       Brigham and Women’s Hospital, Harvard Medical School, Division of Allergy, Immunology and Rheumatology, Boston, United States
1013   Attenuating effects of a metabolised material of clarithromycin, M-4, on dendritic cell activation in vitro
       Kanai, K1; Asano, K2; Furuta, A1; Suzaki, H1
       1School of medicine, Showa University, Otolaryngology, Tokyo, Japan; 2School of NRS, Showa University, Physiology, Yokohoma, Japan

1014   Effects of palmitoylethanolamide on immunological induced histamine, PGD2 and TNFα release from canine skin mast cells
       Cerrato, S1; Brazis, P1; della Valle, F2; Miolo, A2; Puigdemont, A3
       1Univet, I+D, Bellaterra (Barcelona), Spain; 2Innovet Italia, CeDIS, Milano, Italy; 3Universitat Autonoma de Barcelona, Pharmacology, Bellaterra (Bar-

       celona), Spain
1015   Evaluation of the respiratory function in patients with thalassemia: relation to serum feritin levels
       Bourli, E1; Aivazis, V1; Athanasiou - Metaxa, M1; Argyropoulou - Pataka, P2; Tsatra, I1; Sapakos, I1; Nalbanti, P1; Maratou, E1; Stanopoulos, I2
       1Aristotle University of Thessaloniki, 1st Department of Pediatrics, Thessaloniki, Greece; 2Aristotle University of Thessaloniki, Pulmonology Depart-

       ment, Thessaloniki, Greece
1016   Exacerbations of chronic purulent gingivitis in children lead to increased gingival Th2 and decreased gingival Th1 responses
       Bisyuk, Y1; Bisyuk, A1; Sysoyev, N1; DuBuske, L2
       1Crimea State Medical University, Department of Allergy and Immunology, Simferopol, Ukraine; 2Immunology Research Institute of New England,

       Department of Allergy and Immunology, Gardner, MA, United States
1017   Expression of Th1 and Th2-typed cytokines and its significance in nasal polyps
       Pietruszewska, W1; Mlynarski, W2; Kuprys-Lipinska, I3; Kuna, P3
       1Medical University of Lodz, Department of Otolaryngology, Lodz, Poland; 2Medical University of Lodz, Department of Pediatrics, Lodz, Poland;
       3Medical University of Lodz, Dep. of Internal Medicine, Asthma and Allergy, Lodz, Poland

1018   The Th1 type cytokines in psoriatic arthritis versus rheumatoid arthritis
       Ciacli, C; Puschita, M
       Vasile Goldis West University, Department of Immunology, Arad, Romania
1019   Immuno-protective effects of the extremolyte ectoine in animal models and humans
       Bilstein, A; Bernal, F; Klein, J; Stumm, G; Stoehr, T; Lentzen, G
       Bitop AG, MP, Witten, Germany
1020   Interferon-gamma and interferon-gamma receptor 1 gene polymorphisms in patients with lyme disease
       Yanovich, O1; Titov, L1; Scherba, V1; DuBuske, L2
       1
        Research Institute for Epidemiology and Microbiology, Department of Immunology, Minsk, Belarus; 2Immunology Research Institute of New Eng-
       land, Department of Allergy and Immunology, Gardner, MA, United States
1021   Lung cancer with eosinophilic pleural effusion (PE) and blood eosinophilia
       Kaeva, B1; Breskovska, G1; Jovkovski, O1; Kaeva, S2
       1
        Medical Faculty,Skopje, R.Macedonia, Pulmology and Allergology Clinic, Skopje, Macedonia, Fyrom; 2Medical Faculty,Skopje, R.Macedonia, Cardio-
       logy Clinic, Skopje, Macedonia, Fyrom
1022   Measurement and comparison of leptin and C reactive protein in asthmatic and non asthmatic obese adolescentes before and
       after weight loss
       Sanchez-Falconi, R; Sienra-Monge, J; Del Rio-Navarro, B; Del Rio-Chivardi, J
       Hospital Infantil de Mexico Federico Gomez, Allergy and Immunology Department, Mexico City, Mexico
1023   Monocyte-derived dendritic cell maturation and function in patients with acute Hepatitis B and acute Hepatitis C
       Hancharou, A1; Titov, L1; DuBuske, L2
       1
        Research Institute for Epidemiology and Microbiology, Department of Immunology, Minsk, Belarus; 2Immunology Research Institute of New Eng-
       land, Department of Allergy and Immunology, Gardner, MA, United States
1024   Reduced levels of anti-endotoxin IgG antibodies and increased C reactive protein levels are associated with increased fatality in
       patients hospitalised in the intensive care unit
       Beloglazov, V1; Gordienko, A1; Potapov, A1; DuBuske, L2
       1Crimean State Medical University, Department of Allergy and Immunology, Simferopol, Ukraine; 2Immunology Research Institute of New England,

       Department of Allergy and Immunology, Gardner, MA, United States
1025   Usefulness of exhaled nitric oxide (FeNO) measured by a portable analyzer to diagnose cough variant asthma in a clinical setting
       of chronic cough
       Pizzimenti, S1; Heffler, E1; Piccioni, P2; Bugiani, M2; Migliore, E2; Guida, G1; Sciascia, S1; Carosso, A2; Rolla, G1
       1University of Torino - AO Mauriziano, Allergy and Clinica Immunology, Torino, Italy; 2ASL-TO2, Respiratory Medicine, Torino, Italy

1026   Mediators of inflammation in the serum, nasal secretions and nasal polyp’s tissue in patients with nasal polyps and aspirin into-
       lerance
       Kuyan, I1; Kazanova, G2; Mokronosova, M2
       1
        ETN Federal Center, Otorhinolaryngology, Moscow, Russian Federation; 2ENT Federal Center, Department Otorhinolaryngology, Moscow, Russian
       Federation
1027   Role of neuropeptides in the development of atopic dermatitis in children
       Revyakina, V; Sentsova, T; Agafonov, A; Filatova, T; Pavlovskaya, E; Sharapova, K
       Institute of Nutrition RAMS, Moscow, Russia, Department of Allergology, Moscow, Russian Federation
1028   Serum levels of chitotriosidase as a marker of disease activity in sarcoidosis
       Lombardo, G; Giannetto, L; Quattrocchi, P; Crea, C; Lombardo, G
       School and division of Allergy and Clinical Immunology, Human Pathology, Messina, Italy




www.congrex.com/eaaci2009                                                                                      EAACI 2009 Final Programme              151
                                                                                      Posters
POSTERS




           Occupational and Ecematous                                                                                                  The Congress Hall Foyer
          Chairpersons
          Elina Toskala, Finland
          Jan Simon, Germany
          1029       Abstract withdrawn
          1030       Allergic contact dermatitis due to rubber in medical equipment
                     Petrutescu, B1; Dumitru, A1; Bumbacea, R1; Giurcaneanu, C2
                     1Elias Emergency University Hospital, Allergology Department, Bucuresti, Romania; 2Elias Emergency University Hospital, Dermatology Clinic, Bucu-

                     resti, Romania
          1031       Allergic contact dermatitis due to unstandardised cosmetics
                     Porr, C
                     County Hosp., Allergology Department, Sibiu, Romania
          1032       Contact dermatitis in a Portuguese population
                     Barreira, P; Rosmaninho, I; Lopes, I; Moreira Silva, J
                     Centro Hospitalar Gaia/Espinho, EPE, Allergy Department, Vila Nova de Gaia, Portugal
          1033       Nummular eczema due to mercury dental amalgam
                     Pigatto, P1; Brambilla, L2; Ferrucci, S2; Guzzi, G3
                     1University of Milan, Department of Technology for Health, Milan, Italy; 2IRCCS Maggiore Hospital, Mangiagalli and R. Elena Foundation, Institute of

                     Dermatological Sciences, Milan, Italy; 3Italian Association for Metals and Biocompatibility Research – A.I.R.M.E.B., Dental Toxicology, Milan, Italy
          1034       Triclosan contact dermatitis
                     Segura Sánchez, C; Sanchez Ramos, I; Burgos Montero, A; Daza Muñoz, J; Conde Hernandez, J
                     Virgen Macarena University Hospital, Contact Dermatitis, Seville, Spain
          1035       Common and uncommon skin manifestations caused by nickel intake
                     Minciullo, P; Ricciardi, L; Imbesi, S; Venuto, L; Crea, C; Ietto, F; Gangemi, S
                     School and Division of Allergy and Clinical Immunology, Departmen of Human Pathology, Messina, Italy
          1036       First description of contact dermatitis to eupatorium aromatizans, a compositae plant of the Dominican Republic
                     Rubio Perez, M1; Gomez Fernandez, C2; Ramirez Marin, P2; Vidaurrazaga Diaz de Arcaya, C2
                     1Hospital Clinico San Carlos, Allergy and Immunology Department, Madrid, Spain; 2Hospital La Paz, Dermatology Department, Madrid, Spain

          1037       Detection of metal allergy in patients with dental prosthesis
                     Al Faqih, S
                     Baghdad University Hospital, Dental, Baghdad, Iraq
          1038       Occupational airbone contact dermatitis by epoxi systems in a painter of metal structures: a case report
                     Verdú López, P1; Conde-Salazar Gómez, L2; Heras Mendaza, F2; Hernández Santana, G3; Caballero Naranjo, E1; Almeida Quintana, L1; Rodolfo, C1; Te-
                     resa, C1; Nancy, O1; García Dumpierrez, A1; Cumplido Bonny, J1
                     1Hospital Dr. Negrín, Allergy Department, Las Palmas de Gran Canaria, Spain; 2National School of Ocupational Medicine Institute of Health Carlos III,

                     Dermatology Labor, Madrid, Spain; 3Hospital Nuestra Señora de Candelaria, Allergy Department, Santa Cruz de Tenerife, Spain
          1039       Occupational allergical contact dermatitis due to phthalic anhydride
                     Gutierrez, D1; Foncubierta, A2; Leon, A1
                     1Hospital Puerta del Mar, Neumology-Allergy, Cadiz, Spain; 2Joaquin Pece Health Center, Family Medicine, Cadiz, Spain

          1040       Contact dermatitis due to sensitisation to dimethylfumarate
                     Andregnette-Roscigno, V; Arochena, L; Ruiz-García, M; Fernandez-Nieto, M; Sastre, J
                     Fundación Jiménez Díaz, Allergy Department, Madrid, Spain
          1041       Distress vulnerability in patients with drug allergy compared to patients with other psychocutaneous diseases
                     Diaconescu, L1; Tiplica, S2; Iamandescu, I1
                     1University of Medicine and Pharmacy , Dept. of Medical Psychology and Psychosomatics, Bucharest, Romania; 2University of Medicine and Phar-

                     macy , Dept. of Dermatology, Hospital Colentina, Bucharest, Romania

           Drug Allergy Cases and Cohorts                                                                                              The Congress Hall Foyer
          Chairpersons
          Philippe Bousquet, France
          Gulfem Celik, Turkey
          1042      Adverse drug and medical instrument reactions in a pediatric intensive care unit
                    Shockrollah, F
                    Immunology, Asthma and Allergy Research Institute, immunology, Tehran, Islamic Republic of Iran
          1043      Drug allergy: the physician’s and the patient’s perspective
                    Baccioglu, A; Kalpaklioglu, A
                    Kirikkale University, Faculty of Medicine, Department of Allergic Diseases, Kirikkale, Turkey
          1044      Drug allergy caused by antibiotics — one year clinicoepidemiological study
                    Radenkova-Saeva, J; Nikolov, G
                    Emergency Hospital, Clinic of Toxicology, Sofia, Bulgaria
          1045      Empirical analysis of cases of allergic drug reactions
                    Stepanova, E
                    Mechnikov’s Research Institute for Vaccines and Sera, Clinical Allergy Department, Moscow, Russian Federation
          1046      Patients with a positive amoxicillin-clavulanic acid cutaneous test result: a descriptive study
                    García Núñez, I; Barasona Villarejo, M; Medina Fernández, A; Moreno Aguilar, C; Guerra Pasadas, F
                    Hospital Universitario Reina Sofía, Allergy Department, Córdoba, Spain

           152      EAACI 2009 Final Programme                                                                                         www.congrex.com/eaaci2009
                                                                    Posters

1047      Prevalence of drug allergy among medical students: does awareness create any difference?




                                                                                                                                                                    POSTERS
          Bavbek, S1; Oner Erkekol, F1; Celik, G1; Gönüllü, Ý2; Mýsýrlýgil, Z1; Demirel, Y1
          1Ankara University, Department of Allergy, Ankara, Turkey; 2Ankara University, Department of Medical Education, Ankara, Turkey

1048      Paracetamol and propyhenazone hypersensitivity: do combinations cause confusion?
          Gelincik, A1; Ozseker, F1; Buyukozturk, S1; Issever, H2; Colakoglu, B1; Dal, M1
          1Istanbul University, Istanbul Faculty of Medicine, Internal Medicine, Division of Allergy, Istanbul, Turkey; 2Istanbul University, Istanbul Faculty of

          Medicine, Department of Public Health, Istanbul, Turkey
1049      Allergy due to macrolides in children: case reports
          Iparraguirre-Castro, A; García-Gonzales, F; Amo-Vázquez-de-la-Torre, A; Carretero-Anibarro, P; Blanco-Carmona, J; Juste-Picón, S
          Complejo Asistencial de Burgos, Section of Allergology, Burgos, Spain
1050      Bronchospasm due to etoricoxib: a case report
          Dávila, I1; Isidoro-García, M2; Macias, E1; Asensio, T1; Moreno, E1; Ruiz San Francisco, A1; Hierro, B1; Lorente, F1
          1University Hospital, Immunoallergy Service, Salamanca, Spain; 2University Hospital, Biochemistry Service, Salamanca, Spain

1051      Heparin hypersensitivity reaction: case report
          Bant, A; Kruszewski, J; Klos, K; Zakrzewski, A
          Military Institute of Medicine, Department of Infectious Diseases and Allergology, Warsaw, Poland
1052      Hypersensitivity to calcium nadroparin
          Caballero Naranjo, E; Verdú López, P; Castillo Sainz, R; Almeida Quintana, L; Ortega Rodríguez, N; Cumplido Bonny, J; García Dumpierrez, A; Carrillo
          Díaz, T
          Hospital Universitario de Gran Canaria Dr. Negrín, Allergy department, Las Palmas de Gran Canaria, Spain
1053      Type IV- versus Type I- reaction in heparin allergy
          Kerzl, R1; Alexopoulou, A1; Albert, A1; Ring, J2; Darsow, U1
          1Clinic for Dermatology and Allergology, Technical Universtity of Munich, Allergy Department, Munich, Germany; 2Clinic for Dermatology and Al-

          lergology, Technical Universtity of Munich, Director of the Clinic, Munich, Germany
1054      Drug hypersensitivity reactions induced by NSAID in a Lithuanian women
          Varnauskaite, V1; Kvedariene, V2; Nargela, R2
          1
           Vilnius University, Alergologu Clinic, Vilnius, Lithuania; 2Vilnius University, Chest Diseases, Allergology and Radiology Clinic, Vilnius, Lithuania
1055      Allergic reactions to minocycline — presentation to an allergist’s office: a report on 25 patients
          Christodoulou, C
          Private Office, , Nicosia, Cyprus
1056      Allergy to iodinate contrast media
          Bueso Fernandez, A; Perez Pimiento, A; Iglesias Cadalso, A; Rivera Celma, E; Olaverria Pujols, M; Rodriguez Cabreros, M; Garcia Cubero, A
          H.U Puerta de Hierro., Allergy department, Madrid, Spain
1057      Serum sickness like reaction to Amoxicillin and Cefaclor in one infant
          Ozmen, S1; Misirlioglu Dibek, E1; Nacaroglu, T2; Polat, E2
          1Dr. Sami Ulus Maternal and Children Training & Research Hospital, Pediatric Allergy, Ankara, Turkey; 2Dr. Sami Ulus Maternal and Children Training

          & Research Hospital, Pediatrics, Ankara, Turkey

 From Haptens to Hives - Drug Allergy Pearls                                                                                   The Congress Hall Foyer
Chairpersons
Eva Gomes, Portugal
Josefina Rodrigues Cernadas, Spain
1058      Nonsteroidal anti-inflammatory drug hypersensitivity: are single and cross-reactors alike?
          Campina Costa, S1; Neto, M1; Páris Fernandes, N2; Carvalho, F1; Trindade, M1
          1North Lisbon Hospital Center, Pulido Valente Hospital, Immunoallergy Unit, Lisbon, Portugal; 2North Lisbon Hospital Center, Santa Maria Hospital,

          Immunoallergy Department, Lisbon, Portugal
1059      Anaphylactic reaction to chlorhexidine
          Mohedano, E; Garcia Ara, C; Bobolea, I; Diaz Pena, J; Boyano, T; Quirce, S
          Hospital la Paz, Pediatric Allergy Department, Madrid, Spain
1060      Abstract withdrawn
1061      Provocation tests with local anaesthetics: a retrospective study
          Mascarenhas, M; Mendes, A; Costa, C; Lopes da Silva, S; Spínola Santos, A; Pedro, E; Pereira Barbosa, M
          CHLN - Hospital de Santa Maria, Immunoalergology Department, Lisbon, Portugal
1062      Hypersensitivity reactions due to antibiotics: do we need challenge tests for detecting alternative antibiotics?
          Gelincik, A; Buyukozturk, S; Colakoglu, B; Ozseker, F; Dal, M
          Istanbul University, Istanbul Faculty of Medicine, Internal Medicine, Division of Allergy, Istanbul, Turkey
1063      Usefulness of flow cytometry assisted basophil activation test as a safe diagnostic method for aspirin and other nonsteroidal
          anti-inflammatory drugs hypersensitivity
          Cho, Y; Kim, M; Lee, J; Kwon, S
          Ewha Womans University Makdong Hospital, Allergy and Immunology, Seoul, Republic of Korea
1064      Lamotrigine associated DRESS syndrome in an eight-years old girl
          Ozmen, S1; Arik, E2; Tuygun, N2; Ginis, T1; Sikol, G2; Tanir, G3
          1
           Dr. Sami Ulus Maternal and Children Training & Research Hospital, Pediatric Allergy, Ankara, Turkey; 2Dr. Sami Ulus Maternal and Children Training
          & Research Hospital, Pediatrics, Ankara, Turkey; 3Dr. Sami Ulus Maternal and Children Training & Research Hospital, Pediatric Infections, Ankara, Tur-
          key



www.congrex.com/eaaci2009                                                                                           EAACI 2009 Final Programme              153
                                                                                        Posters

          1065      Drug hypersensitivity reactions in children
POSTERS




                    Porebski, G1; Woron, J2; Czarnobilska, E1; Chmielewska, A1; Obtulowicz, K1
                    1Jagiellonian University, Clinical and Environmental Allergology Dep., Krakow, Poland; 2Jagiellonian University, Clinical Pharmacology Dep., Krakow,

                    Poland
          1066      IgE-mediated allergy to oxaliplatin: lack of cross-reactivity with other platinum salts
                    Borrás, J1; Venemalm, L2; Enrique, E3; de Mateo, J3; Castelló, J3; Malek, T3
                    1
                     Hospital Provincial de Castellón, Sección de Alergia, Castellón, Spain; 2Phadia AB, Research and Development, Uppsala, Sweden; 3Hospital General
                    de Castellón, Sección de Alergia, Castellón, Spain
          1067      An algorithmic evaluation of beta-lactam antibiotic allergy
                    Celik, G1; Aydýn, O1; Dogu, F2; Cipe, F2; Boyvat, A3; Ikinciogullari, A2; Akyol, A3; Demirel, Y1
                    1Ankara University, Allergy, Ankara, Turkey; 2Ankara University, Pediatric Immunology and Allergy, Ankara, Turkey; 3Ankara University, Dermatology,

                    Ankara, Turkey
          1068      Adverse reactions to biological drugs in patients with systemic autoimmune diseases
                    Damiolini, E1; Lodi Rizzini, F2; Cinquini, M1; Cattaneo, R3; Cocchi, S2; Facchetti, S2; Gretter, V2; Tosoni, C1
                    1Spedali Civili, Brescia, Allergy Unit, Brescia, Italy; 2Medical School, Brescia University, Chair of Allergy and Clinical Immunology, Brescia, Italy; 3Medi-

                    cal School, Brescia University, Chair of Rheumatology, Brescia, Italy
          1069      Amoxicillin drug hypersensitivity syndrome studied by means of basophil activation test
                    Rodriguez-Trabado, A1; Cámara-Hijón, C2; Fernández-Pereira, L2
                    1Campo Arañuelo Hospital, Allergy Department, Navalmoral de la Mata, Spain; 2San Pedro de Alcántara Hospital, Immunology Department, Cáce-

                    res, Spain
          1070      Severe type I-like hypersensitivity reactions to diclofenac involve allergic effector cells independent of IgE
                    Harrer, A1; Grims, R2; Hawranek, T3; Lang, R3; Lothar, V4; Aberer, W2; Fatima, F1; Himly, M1
                    1University of Salzburg, Dept Molecular Biology, Salzburg, Austria; 2Medical University of Graz, Dept Dermatology, Graz, Austria; 3Paracelsus Medical

                    University of Salzburg, Dept Dermatology, Salzburg, Austria; 4Paul Ehrlich Insitut, Dept Allergology, Langen, Germany
          1071      Diagnostic work up in anaesthesia-related anaphylaxis
                    Rodrigues, J; Vieira, T; Botelho, C; Leblanc, A; Silva, R; Cadinha, S; Castro, E; Castel-Branco, M
                    Hospital of São João, EPE, Allergy and Clinical Immunology Division, Porto, Portugal

           Case Reports, New Therapies and Hypotheses - Part II                                                                              The Congress Hall Foyer
          Chairpersons
          Brigita Sitkauskiene, Lithuania
          Tadeusz Plusa, Poland
          1072        The association of systemic lupus erythematosus and non-Hodgkin’s lymphoplasmocytic lymphoma followed by monoclonal
                      IgM with cold agglutinin activity (case report)
                      Arandjelovic, S; Bogic, M; Raskovic, S; Tomic Spiric, V; Peric Popadic, A; Ojic Rajcic, J
                      Clinical Center of Serbia, Institute of allergy and Immunology, Belgrade, Serbia and Montenegro
          1073        Supportive therapy of intravenous immunoglobulin in patients after autologous bone marrow transplantation
                      Novkovic, A; Petrovic, Z; Ivanovic, A; Cvetkovic, Z; Celeketic, D
                      Clinical Hospital Center Zemun, Haematology and immunology, Zemun, Belgrade, Serbia and Montenegro
          1074        Delayed type hypersensitivity to insulin preparations: a case report
                      Ragaisiene, S; Bajoriuniene, I; Sitkauskiene, B
                      Kaunas University of Medicine, Department of Pulmonology and Immunology, Kaunas, Lithuania
          1075        Successful treatment of cholinergic urticaria with montelukast in children: two case reports
                      Karakas, T; Sackesen, C; Civelek, E; Tuncer, A; Kalayci, O
                      Hacettepe University, Faculty of Medicine, Pediatric Allergy and Asthma Unit, Ankara, Turkey
          1076        Resource utilisation associated with acute and chronic management of hereditary angioedema
                      Wilson, D1; Bork, K2; Cicardi, M3; Rentz, A4; Castaldo, A5; Blaustein, M6
                      1
                        Massachusetts General Hospital Institute of Health Professions, Graduate Program in Clinical Investigation, Boston, MA, United States; 2Johannes
                      Gutenberg University, Dermatology, Mainz, Germany; 3University of Milan, L. Sacco Hospital, Department of Internal Medicine, Milan, Italy; 4United
                      BioSource Corporation, Center for Health Outcomes Research, Bethesda, MD, United States; 5United States Hereditary Angioedema Association, ,
                      New Bedford, MA, United States; 6Dyax Corp., Alliance Management, Cambridge, MA, United States
          1077        Abstract withdrawn
          1078        A case report of stomatitis aphtosa
                      NeziriAhmetaj, L1; Neziri, A2
                      1
                        University Hospital Clinic, Clinical allergology and Immunology, Prishtina, Yugoslavia; 2University Hospital Clinic, Urology, Prishtina, Yugoslavia
          1079        Abstract withdrawn
          1080        Pulmonary involvement in early rheumatoid arthritis: a case report
                      Boccone, A; Del Giacco, S; Serra, P; Manconi, P
                      University of Cagliari, Allergology and Clinical Immunolgy, Monserrato, Italy
          1081        Splenectomy in patients with autoimmune haemolytic anaemia
                      Cvetkovic, Z1; Celeketic, D1; Cvetkovic, B2; Novkovic, A1
                      1Clinical Hospital Center Zemun-Belgrade, Haematology department, Belgrade, Serbia and Montenegro; 2Clinical Hospital Center Zemun-Belgrade,

                      Urology department, Belgrade, Serbia and Montenegro
          1082        Allergic reactions due to skin prick testing to fish extracts
                      Stefanaki, E1; Pitsios, C2
                      1Allergy, Private Practise, Ioannina, Greece; 2Iaso General Hospital, Allergy Dept, Athens, Greece




           154       EAACI 2009 Final Programme                                                                                             www.congrex.com/eaaci2009
                                                                     Posters

1083      Anaphylaxis as presentation of cutaneous mastocytosis: a clinical case




                                                                                                                                                                    POSTERS
          Leblanc, A1; Castro, E1; Botelho, C1; Castro, I2; Castel-Branco, M1
          1Hospital S.João, E.P.E., Allergy and Clinical Immunology Division, Porto, Portugal; 2Hospital S.João, E.P.E., Hematology Division, Porto, Portugal

1084      Acneiform facial rash after intranasal administration of propolis
          Goikoetxea, M; Cabrera-Freitag, P; de la Borbolla, J; Gastaminza, G
          Clínica Universidad de Navarra, Departamento de Alergología e Inmunología Clínica, Pamplona, Spain
1085      Recurrent angioedema: we mustn’t lower our guard
          Dordal Culla, M1; Baltasar Drago, M2; López Andrés, N3; Jurkovicova, J3; Guspí Bori, R2; Muñoz García, E1; Serra Juanpere, R1; Martí Guadaño, E1
          1Fundació Hospital Sant Pere Claver, Unitat Diagnòstic Al.lèrgia Medicamentosa, Barcelona, Spain; 2Hospital de Tortosa Verge de la Cinta, Servei d’Al

          lergologia, Tortosa, Spain; 3Hospital Municipal de Badalona, Servei d’Hematologia, Badalona, Spain
1086      A new pathogenic mutation in cystic fibrosis patients
          Badalzadeh, M1; Sayed Hassani, S2; Dadgar, S3; Aryan, H3; Aryani, O3; Pourpak, Z1; Houshmand, M3
          1Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Genetics Department, Tehran, Islamic Republic of Iran;
          2Clinical Center for infertility, Genetics Department, Yazd, Islamic Republic of Iran; 3Special Medical Center, Genetics Department, Tehran, Islamic

          Republic of Iran
1086b     Combination therapy of rituximab and radiotherapy successfully improved recurrent urticaria in a patient with Schnitzler syn-
          drome associated with B cell lymphoma
          Murota, H1; Shoda, Y2; Ishibashi, T3; Sugahara, H3; Katayama, I1
          1Osaka University, Dermatology, Suita, Japan; 2Sumitomo Hospital, Dermatology, Osaka, Japan; 3Sumitomo Hospital, Hematology, Osaka, Japan



 New Insights into Risk Factors of Occupational Allergy                                                                        The Congress Hall Foyer
Chairpersons
Piero Maestrelli, Italy
Cezary Palczynski, Poland
1087      Occupational asthma due to biguanidine
          Sanchez-Garcia, S1; Fernandez-Nieto, M1; Vega, A2; Garcia del Potro, M1; Sastre, J1
          1
           Fundacion Jimenez Diaz, Servicio de Alergologia, Madrid, Spain; 2Hospital Universitario de Guadalajara, Servicio de Alergologia, Madrid, Spain
1088      Occupational asthma without bronchial hyperresponsiveness in an optical laboratory technician
          Caminoa, M1; Fernandez-Nieto, M2; Barranco, P1; Sastre, B3; del Pozo, V3; Quirce, S1
          1Hospital Universitario La Paz, Allergy service, Madrid, Spain; 2Fundacion Jimenez Diaz, Allergy service, Madrid, Spain; 3Fundacion Jimenez Diaz, In-

          munology service, Madrid, Spain
1089      Occupational asthma due to manganese: a case report
          Wittczak, T; Dudek, W; Krakowiak, A; Walusiak, J; Palczynski, C
          Nofer Institute of Occupational Medicine, Lodz, Poland, Department of Occupational Diseases and Toxicology, £ódŸ, Poland
1090      Contact allergy to paraphenylenediamine: an observation held in the Nofer institute of occupational medicine, Lodz, Poland
          Swierczyñska-Machura, D; Kiec-Swierczyñska, M; Krêcisz, B
          Institute of Occupational Medicine, Centre of Occupational Allergy and Env. Health, Lodz, Poland
1091      Clinical case of occupational severe asthma complicated with chronic obstructive purulent bronchitis
          Fedarushchanka, L
          Belarusian Medical Academy of Post-Graduate Education, Allergy and Occupational Health Department, Minsk, Belarus
1092      Cross-reactive carbohydrate determinants in the diagnosis of occupational allergy - preliminary results
          Wiszniewska, M; Walusiak, J; Zgorzelska-Kowalik, J; Palczynski, C
          Nofer Instytute of Occupational Medicine, Department of Occupational Medicine and Toxycology, Lodz, Poland
1093      Occupational asthma in a cosmetic industry worker caused by inca peanut (plukenetia volubilis linneo)
          Dionicio Elera, J1; Garcia Cubero, A2; Rodríguez, M2; López, M2; Vásquez, A2
          1Puerta de Hierro Majadahonda, Hospital, Allergy Department, Madrid, Spain; 2Puerta de Hierro Hospital, Allergy Department, Madrid, Spain

1094      Frequency of atopy and sensitisation to wood in carpentry apprentices
          Campo, P1; Aranda, A2; Doña, I1; Romero, J1; Garcia-Ruiz, F3; Rodriguez-Bada, J2; Blanca, M1
          1Hospital Universitario Carlos Haya, Allergy, Malaga, Spain; 2Imabis Foundation, Allergy, Malaga, Spain; 3Occupational Medicine Educational Unit,

          Occupational Medicine, Malaga, Spain
1095      Beware of chlorhexidine allergy masquerading as latex allergy
          Nagendran, V1; Ekbote, A2; Onyekwe, T3; Wicking, J4
          1
           Epsom & St Helier University Hospitals NHS Trust, Immunology & Allergy, Carshalton, United Kingdom; 2Epsom & St Helier University Hospitals
          NHS Trust, Immunology & Allergy, Carshalton, United Kingdom; 3Queen Elizabeth Hospital Woolwich NHS Trust, Occupational Health, Woolwich,
          United Kingdom; 4Queen Elizabeth Hospital Woolwich NHS Trust, Clinical Biochemistry, Woolwich, United Kingdom
1096      Respiratory symptoms as a reason for resign from a job
          Wawrzyniak, Z; Stankiewicz-Choroszucha, B; Samolinski, B
          Medical University of Warsaw, Department of the Prevention of Environmental H, Warszawa, Poland
1096b Long-term exposure and health-related quality of life in patients with occupational rhinitis to proteins
          Airaksinen, L1; Luukkonen, R2; Lindstrom, I3; Lauerma, A1; Toskala, E1
          1Finnish Institution of Occupational Health, Control of Hypersensitivity Diseases, Helsinki, Finland; 2Finnish Institution of Occupational Health, Sta-

          tistical Services, Helsinki, Finland; 3Finnish Institution of Occupational Health, Occupational Medicine, Helsinki, Finland




www.congrex.com/eaaci2009                                                                                           EAACI 2009 Final Programme              155
                                                                                      Posters
POSTERS




           Aerobiology                                                                                                                  The Congress Hall Foyer
          Chairpersons
          Lorenzo Cecchi, Italy
          Piotr Rapiejko, Poland
          1097       Allergic plants in the Elbasan region and allergies caused by them during 2004-2008
                     Kallajxhiu, N
                     University “A. Xhuvani”, Biology-Chemistry Department, Elbasan, Albania
          1098       Abstract withdrawn
          1099       The study for the relation between pollen count and outbreak of pollinosis to create the Korean pollen allergy scale
                     Oh, J1; Kim, S2; Kook, M3; Kim, B4; Kang, I5; Lee, H1; Cheong, J6
                     1
                       Hanyang University, Pediatrics, Seoul, Republic of Korea; 2Busan St. Maria Hospital, Pediatrics, Busan, Republic of Korea; 3Kwangju Veteran¡s Hospi-
                     tal, Pediatrics, Kwangju, Republic of Korea; 4Kangneung Asan Hospital, Pediatrics, Kangneung, Republic of Korea; 5Daegu Fatima Hospital, Pediat-
                     rics, Daegu, Republic of Korea; 6Korea University, Pediatrics, Seoul, Republic of Korea
          1100       Two year concentrations of allergen atmospheric fungal spores in Kastamonu, Turkey (2006-2007)
                     Çeter, T1; Pýnar, N2; Yildiz, A2; Güney, K3
                     1Kastamonu University, Faculty of Arts and Sciences, Biology, kastamonu, Turkey; 2Ankara university, Biology, Ankara, Turkey; 3Kastamonu Univer-

                     sity, Faculty of Forestry, Kastamonu, Turkey
          1101       Sampling airborne fungi in a hospital counting simultaneously spores over a glass slide and colony form units (CFU) on petri dis-
                     hes
                     Gonzalo-Garijo, M1; Tormo-Molina, R2; Silva-Palacios, I2; Fernández-Rodríguez, S2
                     1
                       Infanta Cristina University Hospital, Allergology, Badajoz, Spain; 2University of Extremadura, Biology, Badajoz, Spain
          1102       The ragweed’s pollens in Parma (Northern Italy)
                     Albertini, R1; Peveri, S1; Ugolotti, M1; Usberti, I1; Valenti, M1; Dall’Aglio, P1; Ridolo, E2
                     1University of Parma, Clinical Medicine, Nephrology and Heath Sciences, Parma, Italy; 2University of Parma, Clinical Sciences, Parma, Italy

          1103       Clinical prolife in a Mediterranean population sensitised to date palm pollen profilin
                     Huertas, A1; López, M1; Carreño, A1; Larramendi, C2; Ferrer, A3; López-Matas, M4; Carnés, J4
                     1Hospital Santa María del Rosell, Servicio de Alergia, Cartagena (Murcia), Spain; 2Hospital Marina Baixa, Unidad de Alergia, Villajoyosa (Alicante),

                     Spain; 3Hospital de la Vega Baja, Unidad de Alergia, Orihuela (Alicante), Spain; 4Laboratorios LETI S.L., R&D, Madrid, Spain
          1104       Pollen counts and their relationship with meteorological parameters in Ankara, Turkey between 2005-2008
                     Civelek, E1; Kizilpinar, Ý2; Soyer, O1; Dogan, C2; Tuncer, A1; Sackesen, C1
                     1
                       Hacettepe University, Faculty of Medicine, Pediatric Allergy and Asthma Unit, Ankara, Turkey; 2Hacettepe University, Faculty of Science, Biology,
                     Ankara, Turkey
          1105       Counts of airborne Cladosporium and Alternaria spores in Ankara in 2005-2008 and their relationship to meteorological parame-
                     ters
                     Kizilpinar, Ý1; Civelek, E2; Ozmen, E1; Soyer, O2; Sackesen, C2; Tuncer, A2
                     1Hacettepe University, Faculty of Science, Biology, Ankara, Turkey; 2Hacettepe University, Faculty of Medicine, Pediatric Allergy and Asthma Unit,

                     Ankara, Turkey
          1106       Plantago pollen allergen Pla l 1: quantification in the atmosphere and relation with pollen counts
                     González-Parrado, Z1; Valencia, R1; Vega, A1; Monsalve, R2; Mandrioli, P3; Fernández-González, D1
                     1
                       University of León, Biodiversity and Environmental Management, León, Spain; 2Alk-Abello, I+D, Madrid, Spain; 3ISAC/CNR, Aerobiology Depart-
                     ment, Bologna, Italy
          1107       Pollen counts in hair washes
                     Charpin, D1; Pichot, C2; Charpin-Kadouch, C3; Penel, V4; Calleja, M5
                     1
                       Assistance Publique-Hôpitaux de Marseille, Department of Pneumonoly & Allergy, Marseille, France; 2National Institute for Agronomy, Unité de
                     Recherches Forestières Méditerranéenes, Avignon, France; 3Association Conseil Habitat-Santé, Conseil Habitat-Santé, Marseille, France; 4Laboratoire
                     des Allergènes, Laboratoire des Allergènes, Valence, France; 5National Institute for Agronomy, Supagro, Montpellier, France
          1108       Component resolved diagnosis of grass pollen allergic patients from Spain
                     Nuñez Acevedo, B1; Barreales Tolosa, L2; Vázquez-Cortés, S1; Casco Martín, F1; Carballo Martín, M1; García Sifuentes, L1; Martínez Cócera, C1; Fernán-
                     dez-Rivas, M1
                     1
                       Hospital Clínico San Carlos, Allergy Department, Madrid, Spain; 2Hospital Clínico San Carlos, Epidemiology Department, Madrid, Spain
          1109       Clinical characterisation of platanus pollinosis in patients referred to a allergy out-patient clinic in Setúbal
                     Vasconcelos, A1; Pires, A2; Tomaz, E3; Inácio, F3
                     1Hospital S. Bernardo Setúbal, EPE, Allergology Department, Setúbal, Portugal; 2Hospital S. Bernardo Setúbal, Allergy Department, Setúbal, Portu-

                     gal; 3Hospital S. Bernardo Setúbal, Allergology Department, Setúbal, Portugal
          1110       Newly sensitised patients to ragweed (ambrosia artemisiifolia) pollen in the Geneva area
                     Gumowski, P1; Davet, A1; Clot, B2; Van Eck, F1; Gaudart, M1
                     1INRAAIC, Allergy & Clinical Immunology Research Institute, Meyrin, Switzerland; 2MeteoSuisse, Station Aerologique, Payerne, Switzerland

          1111       Aeroallergen monitoring in Kiev, Ukraine in 2007 and 2008 demonstrates substantial amounts of ragweed allergen
                     Turos, O1; Kovtunenko, I1; Markevych, Y1; DuBuske, L2
                     1Marzeev Institute for Hygiene and Medical Ecology, Academy of Medical Sciences of Ukraine, Kiev, Ukraine; 2Immunology Research Institute of

                     New England, Department of Allergy and Immunology, Gardner, MA, United States
          1112       Clinical index: a tool for the determination of the allergic risk
                     Thibaudon, M; Oliver, G
                     RNSA, Pollens, Saint Genis l’Argentière, France




           156       EAACI 2009 Final Programme                                                                                         www.congrex.com/eaaci2009
                                                                      Posters




                                                                                                                                                                         POSTERS
 Late Breaking Poster Session - Food Allergy - Difficulties in Diagnosis                                                          The Congress Hall Foyer
Chairpersons
Barbara Rymarczyk, Poland
Anna Sokolova, Portugal
1484      Prevalence of food allergy among students in Mashhad city, Northeast Iran: a questionnaire study
          Varasteh, A1; Assarehzadegan, M2; Sankian, M1; Abolhassani, A3; Amini, A4; khakzad, M5
          1
           Mashhad University of Medical Sciences, Immunology, Mashhad, Islamic Republic of Iran; 2Ahvaz Jundishapur University of Medical Sciences, Im-
          munology, Ahvaz, Islamic Republic of Iran; 3Mashhad Tarbiat Moallem University, Mashhad Tarbiat Moallem University, Mashhad, Islamic Republic
          of Iran; 4Aviccena Research Institute, Immunology, Mashhad, Islamic Republic of Iran; 5Islamic Azad University of Mashhad, Basic Sciences,
          Mashhad, Islamic Republic of Iran
1485      Food allergy and eczema in Italian pediatric cohort: no association with TLR-2 and TLR-4 polymorhisms
          Galli, E1; Alessandra, C2; Stefania, C2; Cristiano, P2; Simona, A2; Valentina, A2; Giorgio, M2; Vito Domenico, C3
          1San Pietro Hospital Fatebenefratelli Rome Italy, Research Center, Via Cassia 600, 00189, Rome, Italy; 2San Pietro Hospital Fatebenefratelli Rome Italy,

          Research Center, Rome, Italy; 3University “La Sapienza”, II School of Medicine, Rome, Italy
1486      An anaphylactic shock in a fourteen years-old boy by cross-contamination of bovine meat in a chicken and pork hamburger
          Tripodi, S1; Di Rienzo Businco, A2; Lambiase, C2; Restani, P3
          1Sandro Pertini Hospital, Rome, Italy., Pediatric Allergy Unit, via dei Monti tiburtini 385, 00100, Roma, Italy; 2Sandro Pertini Hospital, Rome, Italy., Pe-

          diatric Allergy Unit, Roma, Italy; 3State University of Milan, Italy, Dept. of Pharmacological Sciences, Milan, Italy
1487      An anphylactic shock in a eleven years-old girl by hidden Hens’ egg in mortadella (a large Italian sausage)
          Tripodi, S1; Di Rienzo Businco, A1; Lambiase, C1; Restani, P2; Cavallina, R3; Campagna, M3
          1Sandro Pertini Hospital, Rome, Italy., Pediatric Allergy Unit, Roma, Italy; 2State University of Milan, Italy, Dept. of Pharmacological Sciences, Milan,

          Italy; 3Regioni Lazio e Toscana, Istituto Zooprofilattico Sperimentale, Rome, Italy
1488      The Anaphylaxys is increasing in Romania
          Deleanu, D1; Bujor, A2; Pastor, C3; Itu, I3
          1University of Medicine & Pharmacy, Dept. Allergy, O. Ghibu 19, 400185, Cluj-Napoca, Romania; 2Univ Med & Pharm Iluliu Hatieganu, Allergy Dept,

          Cluj-Napoca, Romania; 3Emergency Hospital Octavian Fodor, Allergy Dept, Cluj-Napoca, Romania
1489      Histamine in Beer
          Muelleneisen, N
          Asthma und Allergiezentrum Leverkusen, 51371, Leverkusen, Germany
1490      Efficiency of the new diagnostic criteria for food anaphylaxis in Italy
          Calvani, M1; Cardinale, F2; Martelli, A3; Muraro, A4; Pucci, N5; Savino, F6; Zappala, D7; Panetta, V8
          1
           S. Camillo - Forlanini Hospital, Departments of Pediatrics, Circonvallazione Gianicolense, Rome, Italy; 2University of Bari, Clinica Pediatrica 1, Bari,
          Italy; 3University of Milan, medical school, Department of Child & Maternal Medic, Milan, Italy; 4University of Padua, Department of Paediatrics,
          Padua, Italy; 5University of Florence, “A.Meyer”Children Hospital, Florence, Italy; 6University of Turin, Department of Paediatrics, Turin, Italy; 7Policli-
          nico Umberto 1o, La Sapienza University of Rome, Department of Paediatrics, Rome, Italy; 8Fatebenefratelli Association for the Research. Isola Tibe-
          rina,, Medical Statistics & Information Technology, Rome, Italy
1491      Allergy to cow’s milk and egg: the performance of a component-based allergen microarray in clinical practice
          Cavagni, G1; D’Urbano, L2; Donnanno, S1; Artesani, M1; Pellegrino, K1; Luciano, R3; Riccardi, C1; Tozzi, A4; Ravà, L4; Carloni, E4; De Benedetti, F2
          1UOC Allergologia Pediatrica, Italy; 2Laboratorio di Reumatologia, Italy; 3UO Laboratorio di Analisi, Italy; 4IRCCS Ospedale Pediatrico Bambino Gesù,

          UOC Epidemiologia, Roma, Italy
1492      Glatiramer anaphylaxis: Antibodies and Basophil Activation Test to Glatiramer
          Soriano, V1; Marco, F2; Perez, A3; Gonzalez, P4
          1Universitary General Hospital, Allergy Service, Maestro Alonso, 109, 03010, Alicante, Spain; 2Alicante University, Biotechnology Department, Ali-

          cante, Spain; 3Universitary General Hospital, Neurology Service, Alicante, Spain; 4Universitary General Hospital, Allergy Service, Alicante, Spain
1493      IFN-γ-induced Specific Oral Tolerance Induction (ISOTI) of Non-IgE-mediated Food Allergy with Late Eczematous Reactions
          Noh, G1; Lee, J2; Jin, H2; Noh, J3; Lee, W4; Lee, S2
          1Seoul Allergy Clinic, Allergy and Clinical Immunology, Seoul, Republic of Korea; 2Hanyang University, College of Human Ecology, Food and Nutri-

          tion, Seoul, Republic of Korea; 3Konkuk Univerisity, College of Animal Bioscience & Technology, Animal Biotechnology, Seoul, Republic of Korea;
          4Eulji University, Food Science, Sungnam, Republic of Korea

1494      Severe allergic reactions to cooked green bean: the culprit protein is a lipid transfer protein
          Pravettoni, V1; Farioli, L2; Conti, A3; Scibilia, J2; Primavesi, L4; Piantanida, M4; Pastorello, E2
          1
           IRCCS Foundation Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Clinical Allergy and Immunology Unit, via Pace 9, 20122, Milan, Italy;
          2Niguarda Ca’ Granda Hospital, Allergology and Immunology Unit, Milan, Italy; 3ISPA, National Research Council, Turin, Italy; 4IRCCS Foundation Os-

          pedale Maggiore Policlinico, Mangiagalli e Regina Elena, Clinical Allergy and Immunology Unit, Milan, Italy
1495      The clinical relevance of in vivo/in vitro tests for cereal and peanut sensitisation in grass pollen allergic patients
          Martens, M; Schnoor, H; Hans J, M; Poulsen, L
          Copenhagen University Hospital, Allergy Clinic, Copenhagen, Danmark
1496      Occupational allergy to bell pepper pollen in greenhouses in The Netherlands, an 8-year follow-up study
          Patiwael, J1; De Jong, N2; Burdorf, A3; de Groot, H4; Gerth van Wijk, R2
          1Erasmus MC, section of Allergology, Burgemeester s’ Jacobplein 51, Box 2040, 3000 CA, Rotterdam, The Netherlands; 2Erasmus MC, section of Al-

          lergology, Rotterdam, The Netherlands; 3Erasmus MC, Department of Public Health, Rotterdam, The Netherlands; 4Reinier de Graaf Groep, Allergy
          centre, Voorburg, The Netherlands




www.congrex.com/eaaci2009                                                                                              EAACI 2009 Final Programme              157
                                                                                       Posters

          1497      Longitudinal validity and responsiveness of the Food Allergy Quality of Life Questionnaire — Parent Form (FAQLQ-PF) in child-
POSTERS




                    ren 0-12 years following positive and negative food challenges
                    DunnGalvin, A1; Cullinane, C2; Flokstra-de Blok, B3; Dubois, A3; Hourihane, J2
                    1Clinical Investigation Unit Cork University Hospital, Department of Paediatrics and Child Health, Clinical Investigation Unit Cork University Hosp.,

                    Cork, Ireland; 2University College, Department of Paediatrics and Child Health, Cork, Ireland; 3University of Groningen, 2Department of Paediatrics,
                    Division of Paediatric, Groningen, The Netherlands

           Late Breaking Poster Session - Immunodeficiency and Automimmune Syndromes                                                     The Congress Hall Foyer
          Chairpersons
          Joanna Makowska, Poland
          Ana Todo-Bom, Portugal
          1498      Impaired regulatory T-cell homeostasis due to Vitamin D deficiency in Undifferentiated Connective Tissue Disease
                    Zold, E1; Szodoray, P2; Kappelmayer, J3; Gaal, J4; Csathy, L3; Barath, S1; Gyimesi, E1; Zeher, M1; Szegedi, G1; Bodolay, E1
                    1University of Debrecen HUNGARY, 3rd Department of Internal Medicine, Debrecen, Hungary; 2University of Oslo, Oslo, Immunobiological Labora-

                    tory, Oslo, Norway; 3University of Debrecen HUNGARY, Department of Clinical Biochemistry, Debrecen, Hungary; 4Kenezy Country Hospital, De-
                    partment of Rheumatology, Debrecen, Hungary
          1499      Mixed connective tissue disease (MCTD): phenotypes and immunological characteristics
                    Hajas, A1; Szodoray, P2; Demeter, N3; Zold, E1; Dezso, B4; Csipo, I1; Tumpek, J1; Bodolay, E1
                    1University of Debrecen HUNGARY, 3rd Department of Internal Medicine, Debrecen, Hungary; 2University of Oslo, Oslo, Immunobiological Labora-

                    tory, Oslo, Norway; 3University of Pécs, Department of Nuclear Medicine, Medicine Faculty, Pécs, Hungary; 4University of Debrecen HUNGARY, De-
                    partment of Pathology, Debrecen, Hungary
          1500      Simple urticaria as the initial manifestation of SLE: Why The(y) Wait ?
                    Kutlu, A1; Ozturk, S2; Onem, Y3; Nalbant, S3; Kiralp, M4; Taskapan, O2
                    1Gülhane Military Medical Academy Haydarpaþa Training Hospital, Allergy Department, Gülhane Military Medical Academy Haydarpaþa Traini, Is-

                    tanbul, Turkey; 2Gülhane Military Medical Academy Haydarpaþa Training Hospital, Allergy Department, Istanbul, Turkey; 3Gülhane Military Medical
                    Academy Haydarpaþa Training Hospital, Internal Medicine Department, Istanbul, Turkey; 4Gülhane Military Medical Academy Haydarpaþa Training
                    Hospital, Department of Physical Medicine, Istanbul, Turkey
          1501      The effectiveness of antihistamines in up to four-times conventional doses on urticarial discomfort and quality of life in diffic-
                    ult-to-treat urticaria
                    Church, D1; Baiardini, I2; Staevska, M3; Popov, T3; Kralimarkova, T3; Dimitrov, V3; Church, M4
                    1University of Southampton, Allergy and Inflammation Research, Mail point 825, Southampton General Hospital, SO16 6YD, Southampton, United

                    Kingdom; 2University of Genoa, Allergy and Respiratory Diseases, Genoa, Italy; 3Medical University of Sofia, Clinical Centre of Allergology, Sofia, Bul-
                    garia; 4Charité-Universitätsmedizin Berlin, Allergy and Dermatology, Berlin, Germany
          1502      Recombinant C1 inhibitor for Acute Attacks of Hereditary Angioedema
                    Reshef, A1; Leibovich, I2
                    1
                      Sheba Medical Center, Allergy & Immunology, Tel-Hashomer, Israel; 2Sheba Medical Center, Angioedema Center, Tel Hashomer, Israel
          1503      Plasma kallikrein activation in patients with hereditary angioedema due to C1 inhibitor deficiency
                    Zanichelli, A; Maggioni, L; Cicardi, M
                    University of Milan, Department of Medical Sciences, Milan, Italy
          1504      Adverse reactions to biological agents: role of anti-infliximab antibodies and analysis of potential risk factors
                    Matucci, A1; Vultaggio, A1; Nencini, F2; Pratesi, S2; Rossi, O1; Parronchi, P2; Romagnani, S2; Maggi, E1
                    1Dept Biomedicine, Immunoallergology Unit, Florence, Italy; 2Center DENOTHE, Internal Medicine, Florence, Italy

          1505      Life expectancy of patients with Leukocyte Adhesion Deficiency in Iran
                    Mozaffari, H1; Pourpak, Z2; Bemanian, M2; Gharagoozlou, M2; Movahedi, M2; Aghamohammadi, A2
                    1
                      Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran; 2Immunology,
                    Asthma and Allergy Research Institute, Children Medical Center, Tehran, Islamic Republic of Iran
          1506      A case of toxocariasis presenting as chronic urticaria
                    Qualizza, R; Incorvaia, C
                    Istituti Clinici di Perfezionamento, Allergy Department, Milano, Italy
          1507      Delayed onset of (T-B+NK+) (Severe) Combined Immunodeficiency (S)CID: Complete IL7 receptor deficiency in a 22 month year
                    old girl
                    Rossberg, S1; von Bernuth, H2; Susanne, L2; Schwarz, K3; Ebell, W4; Wahn, V2
                    1University Hospital Charité Berlin, Department of Pediatric Pneumology and Immunology, Augustenburger Platz 1, 13353, Berlin, Germany; 2Uni-

                    versity Hospital Charité Berlin, Department of Pediatric Pneumology and Immunology, Berlin, Germany; 3University of Ulm, Institute for Transfusion
                    Medicine, Ulm, Germany; 4University Hospital Charité Berlin, Department of General Pediatrics, Berlin, Germany
          1508      Sjogren syndrome and yeast allergy
                    Corrocher, G1; Martinelli, N2; Di Lorenzo, G3; Biasi, D2; Bambara, L2; Caramaschi, P2; Pacor, M2
                    1
                      University of Verona, Dipartimento di Scienze Morfologico-Biomediche Sez, Verona, Italy; 2University of Verona, Department of Clinical and Experi-
                    mental Medicine, Verona, Italy; 3University of Palermo, Dipartimento di Medicina Clinica e delle Patologie, Palermo, Italy
          1509      The role of TGF-beta1 at the pathogenesis of Rheumatoid Arthritis
                    Yatsyshyn, R1; Neyko, Y2; Yatsyshyn, N2
                    1
                      Medical University, Internal Medicine, P.Orlyk str.5/3, 76018, Ivano-Frankivsk, Ukraine; 2Medical University, Internal Medicine, Ivano-Frankivsk,
                    Ukraine
          1510      Potential role of interleukin-1 beta in the stimulation of nitric oxyde production in patients with systemic sclerosis
                    Yatsyshyn, R1; Neyko, Y2; Yatsyshyn, N2
                    1
                      Medical University, Internal Medicine, P.Orlyk str.5/3, 76018, Ivano-Frankivsk, Ukraine; 2Medical University, Internal Medicine, Ivano-Frankivsk,
                    Ukraine


           158       EAACI 2009 Final Programme                                                                                         www.congrex.com/eaaci2009
                                                                         Posters

1511       Up-regulation of CCL2 production in Chronic Idiopathic Urticaria patients




                                                                                                                                                                              POSTERS
           Santos, J; Azor, M; Lourenço, F; Futata, E; Damante, I; Prearo, E; Rivitti, E; Duarte, A; Sato, M
           University of Sao Paulo, Dermatology, São Paulo, Brazil
1512       Urticaria due intradermal test with articaine hydrochloride
           Sánchez-Morillas, L; Dávila Fernández, G; Rojas Perez-Ezquerra, P; Laguna Martinez, J; Santos, A; Gomez-Tembleque Ubeda, P; Blanco Moratiel, H
           Hospital Central de la Cruz Roja, Allergology Department, Madrid, Spain
1513       Prevalence of hypersensitivity reactions to nonsteroidal antiinflamatory drugs in 212 patients with mastocytosis in Spain
           Sánchez-Matas, I1; Matito-Bernechea, A2; Gonzalez de Olano, D3; Álvarez-Twose, I2; Sánchez-Muñoz, L2; de la Hoz Caballer, B4; Escribano, L2
           1Hospital Virgen del Valle, Mast Cell Unit, Ctra. Cobisa s/n, Toledo, Spain; 2Hospital Virgen del Valle, Mast Cell Unit, Toledo, Spain; 3Hospital de Fuen-

           labrada, Allergy Department, Madrid, Spain; 4Hospital Ramón y Cajal, Allergy Department, Madrid, Spain
1514       Evolution of mast cells-mediator related symptoms in pregnant women with mastocytosis: A retrospective study in 23 pregnan-
           cies by the Spanish Network on Mastocytosis (REMA)
           Matito, A1; Sánchez-Matas, I1; Villasevil, E2; Álvarez-Twose, I1; Sánchez-Munoz, L1; González de Olano, D3; Escribano, L1
           1Hospital Virgen del Valle, Mast Cell Unit, Red Española de Mastocitosis, Toledo, Spain; 2Hospital Carlos III, Unidad de Calidad, Madrid, Spain; 3Hospi-

           tal de Fuenlabrada, Allergy Department, Madrid, Spain
1515       Angioedema after ingestion of rifampicin
           Gómez Galán, C; Ferre Ybarz, L; Torredemer Palau, A; Nevot Falcó, S
           Hospital Sant Joan de Déu, Althaia Manresa, Allergy Section, Pediatric Department, Manresa, Spain
1516       Ultrasound gel: An unusual cause of cold urticaria
           Perez-Calderon, R; Gonzalo-Garijo, M; Perez-Rangel, I; Sanchez-Vega, S
           Infanta Cristina University Hospital, Allergology, Badajoz, Spain

 Late Breaking Poster Session - Allergen Immunotherapy and Hymenoptera Sting Allergy The Congress Hall Foyer
Chairpersons
Radoslaw Gawlik, Poland
Ulrich Müller, Switzerland
1517      Comparison of Phlp5 content in sublingual preparations for immunotherapy in allergy
          Fahlbusch, B; Khachaturyan, L; Agsten, J; Mankowski, D; Markert, U
          Friedrich-Schiller-University Jena, Department of Obstetrics, Jena, Germany
1518      Desensilization to aspart insulin
          Díaz Angulo, S1; Rodríguez Fernández, F1; Jiménez Gómez, I1; Antón Casas, M1; Duque Gómez, S1; Martin-Gil Granados, D1; Perdomo Gutiérrez, G1;
          Pellón Fernández, L2; Alonso Juaristi, S2
          1Valdecilla´s Universitary Hospital, Allergy Department, Santander, Spain; 2Sierrallana´s Hospital, Allergy Department, Torrelavega, Spain

1519      Efficacy and Safety of Sublingual Specific Immunotherapy in Children
          Verini, M1; Cingolani, A2; Rapino, D2; Consilvio, N2; Spaguolo, C2; Di Pillo, S2; Chiarelli, F3
          1
            University of Chieti, Paediatric Clinic, Clinical Hospital Colle dell’Ara, 66100, CHIETI, Italy; 2Allergological Paediatric Service, Paediatric Clinic, Univer-
          sity of Chieti, Italy; 3Paediatric Clinic, Clinical Hospital, University of Chieti, Italy
1520      Test symptom severity questionnaire and Linker scale for clinical evaluation of sublingual immunotherapy efficacy in children
          with allergic rhinitis
          Rojo Gutiérrez, M1; Bermejo, M1; Mellado, J1; Martinez, N2; Ramirez, G1
          1Juarez Hospital, Allergy Department, Mexico City DF, Mexico; 2Juarez Hospital, Internal Medicine, Mexico city DF, Mexico

1521      Change of the fractional exhaled nitric oxide (FENO) following sting challenge tests
          Arnold, A; Walker, A; Przybilla, B; Ruëff, F
          Ludwig-Maximilian University, Department of Dermatology and Allergology, Munich, Germany
1522      Safety of accelerated schedules of allergen-immunotherapy in the treatment of atopic dermatitis
          Nahm, D1; Sung, J1; Lee, J1; Park, H1; Choi, G1; Park, H1; Jeon, S2
          1
            Ajou University Hospital, Department of Allergy and Rheumatology, Suwon, Republic of Korea; 2Yonsei-Ajou Clinic, Department of Pediatrics,
          Gwang-Ju, Republic of Korea
1523      Clinical efficacy of accelerated schedules of allergen-immunotherapy in the treatment of severe atopic dermatitis
          Nahm, D1; Lee, H1; Sung, J1; Lee, J1; Choi, G1; Park, H1; Park, H1; Jeon, S2
          1
            Ajou University Hospital, Department of Allergy and Rheumatology, Suwon, Republic of Korea; 2Yonsei-Ajou Clinic, Department of Pediatrics,
          Gwang-Ju, Republic of Korea
1524      Immunotherapy with inhalant allergens in a cluster protocol
          Cárdenas, R; Beitia, J; Vega, A; Alonso, A
          H.U.Guadalajara, Allergy, Guadalajara, Spain
1525      Anaphylactic sting reactions to Dolichovespula media (Retzius 1783)
          Kroth, J1; Mauss, V2; Przybilla, B1; Rueff, F1
          1Ludwig Maximilian University, Department of Dermatology and Allergology, Munich, Germany; 2Centre for Wasp Sciences, Research, Consulting,

          Conservation, Michelfeld, Germany
1526      Acetylsalicylic acid (ASA) desensitization before coronary stenting in allergic patients, 3 years experience
          Cortellini, G1; Santarelli, A2; Santucci, A3; Piovaccari, G2; Corvetta, A3
          1
            Rimini Hospital, Internal Medicine, via Settembrini 2, 47900, Rimini, Italy; 2Rimini Hospital, Cardiology, Rimini, Italy; 3Rimini Hospital, Internal Medi-
          cine, Rimini, Italy
1527      Induction of oral tolerance to peanut: a safe and effective home-based regimen
          Ojeda, P1; Alfaya, T1; Pineda, F2; Ojeda, I1
          1
            Clinica de Asma y ALergia dres. Ojeda, Allergy, Madrid, Spain; 2Diater Pharmaceuticals, Research Department, Madrid, Spain


www.congrex.com/eaaci2009                                                                                                  EAACI 2009 Final Programme                159
                                                                                          Posters

          1528       Identification of cockroach allergen using proteomic analysis
POSTERS




                     Barbosa, M1; Santos, A1; Santos, L2; Palma, M2; Ferreira-Briza, F3; Briza, P3; Erler, A3; Pomés, A4; Arruda, L1
                     1School of Medicine of Ribeirão Preto - University of São Paulo, Department of Medicine, Ribeirão Preto, Brazil; 2Biosciences Institute, State Univer-

                     sity of Sao Paulo, Social Insects Center, Rio Claro, Brazil; 3University of Salzburg, Molecular Biology, Salzburg, Austria; 4Indoor Biotechnologies, Mole-
                     cular Biology, Charlottesville, United States


          Poster Group 3                                                                               Tuesday 9 June                                   12.00 – 13.30
           Allergy and Asthma Epidemiology                                                                                                                              Annex
          Chairpersons
          Peter Burney, United Kingdom
          Fulvio Braido, Italy
          1113       Large scale questionnaire survey on respiratory health in Sweden: effects of late- and non-response
                     Ronmark, E1; Ekerljung, L1; Lötvall, J2; Torén, K3; Ronmark, E4; Lundback, B1
                     1
                       University of Gothenburg, H. Krefting Center for Asthma and Allergy Research, Gothenburg, Sweden; 2University of Gothenburg, Dep. of Internal
                     Medicine/Respiratory Medicine, Gothenburg, Sweden; 3University of Gothenburg, Dep. of Environmental and Occupational Medicine, Gothenburg,
                     Sweden; 4Sunderby Central Hospital of Norrbotten, Dep. of Medicine/OLIN-studies, Luleå, Sweden
          1114       Prevalence of allergic diseases in an urban adult population assessed by mailing questionnaires - GA2LEN survey results in Lodz
                     Makowska, J; Zarominska, D; Kowalski, M
                     Medical University of Lodz, Poland, Department of Immunology, Rheumatology and Allergy, Lodz, Poland
          1115       Epidemiology of COPD and asthma in the general adult population of Poland
                     Elgalal, A; Kuprys-Lipinska, I; Tworek, D; Kuna, P
                     Barlicki University Hospital, Division of Internal Medicine, Asthma and Allergy, Lodz, Poland
          1116       Comorbidity of asthma and rhinitis in patients attending outpatient clinics of Spanish allergists, primary care physicians and
                     pulmonologists
                     Castillo, J1; Valero, A2; Quirce, S3; Navarro, A4; Mullol, J5; Molina, J6; Garcia Marcos, L7; Juliá, B8
                     1Servei de Pneumologia, Institut Universitari Dexeus, Barcelona, Spain; 2Unitat de Al.lèrgia. Servei de Pneumología i Al.lèrgia Respiratòria., Hospital

                     Clinic., Barcelona., Spain; 3Servicio de Alergia, Hospital La Paz, Madrid, Spain; 4Servicio de Alergia, Hospital el Tomillar, Sevilla, Spain; 5Unitat de Rino-
                     logia i Clínica de l’Olfacte, Servei d´ORL,, Hospital Clínic, IDIBAPS., Barcelona, Spain; 6Centro de Salud Francia, Grupo de Respiratorio, semFyC., Mad-
                     rid, Spain; 7Servicio de Pediatría, H. Virgen de la Arrixaca, Murcia, Spain; 8Medical Department, MSD, Madrid, Spain
          1117       The influence of promotion on the response rate in the ECAP survey
                     Samel-Kowalik, P; Tomaszewska, A; Raciborski, F; Lusawa, A; Walkiewicz, A; Borowicz, J; Gutowska, J; Samolinski, B
                     Medical University of Warsaw, Prevention of Enviromental Hazards and Allergology, Warsaw, Poland
          1118       Duration and economic burden of acute asthma in children 1 - 14 years in 2007 in Tehran
                     Dashti, R1; Pourpak, Z1; Fazlollahi, M1; Bavarian, B2; Sedighy, M2; Moin, M1
                     1
                       Immunology, Asthma and Allergy Research Institute, Children’s Medical Center, Tehran, Islamic Republic of Iran; 2Children Hospital Medical Center,
                     Emergency Department, Tehran, Islamic Republic of Iran
          1119       Age dependent fluctuations in asthma prevalence in two population-based studies among 20-44 year old Danes
                     Thilsing, T; Al-kalemji, A; Baelum, J
                     Odense University Hospital, Department of Occupational Health, Odense, Denmark
          1120       Evaluation of the prevalence of high birth weight in 5-15 years old asthmatic children referring to Kashan asthma and allergy
                     clinic in 2007 in Iran
                     Heidarzadeh Arani, M1; Ahmadi, A2
                     1
                       Kashan Medical Science University, Pediatric, Kashan, Islamic Republic of Iran; 2Kashan of Medical Science University, Pediatric, Kashan, Islamic Re-
                     public of Iran
          1121       Prevalence of bronchial asthma and association with environmental tobacco smoke exposure amongst girl school-children in
                     Delhi, India
                     Raj, N1; Kumar, R2; Singh, P3; Malik, A3; Kumar, H3
                     1
                       Health Care Charitable Institute, Child Health and Maternity Health, Delhi, India; 2VP Chest Institute, University of Delhi, Respiratory Allergy & Ap-
                     plied Immunology, Delhi, India; 3VP Chest Institute, University of Delhi, Respiratory Medicine, Delhi, India
          1122       Characteristics and dynamics of allergic respiratory diseases — 8 year research
                     Breskovska, G1; Kaeva, B1; Stevcevska, G1; Stojkovic, J1; Breskovska, H2; Pejkovska, S1
                     1
                       Medical faculty, Pulmology and allergology clinic, Skopje, Macedonia, Fyrom; 2Medical faculty, Dermatology clinic, Skopje, Macedonia, Fyrom
          1123       Association between asthma and allergic rhinitis and conjunctivitis in a Turkish population
                     Ceyhan, B; Eryuksel, E; Yapali, S; Yildirim, F
                     Marmara University School of Medicine, Department of Pulmonary Medicine, Istanbul, Turkey
          1124       The prevalence of atopic diseases in the general adult population
                     Todorova, A1; Jaeger, T2; Schaefer, T3; Wichmann, H4; Ring, J1; Weidinger, S2
                     1
                       Department of Dermatology and Allergy , Technical University Munich, Department of Dermatology and Allergy, Munich, Germany; 2Department
                     of Dermatology and Allergy , Technical University Munich, Division of Environmental Dermatology and Allergy, Munich, Germany; 3Institute of So-
                     cial Medicine, Luebeck University, Institute of Social Medicine, Luebeck, Germany; 4HelmholtzZentrum Muenchen-German research center for en-
                     vironmental Health, Epidemiology Departement, Munich, Germany
          1125       Prevalence and clinical severity of ragweed allergy in a health care population in Magenta town: an epidemilogical study on
                     1373 subjects
                     Maira, B1; Milani, M2
                     1Azienda Sanitaria 1 Provincia di Milano, Unità Operativa Igiene e Sanità Pubblica, Milan, Italy; 2ALK Abellò, Medical Department, Lainate, Italy




           160       EAACI 2009 Final Programme                                                                                               www.congrex.com/eaaci2009

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:667
posted:5/5/2011
language:English
pages:26